Menu
Back to Journals » ClinicoEconomics and Outcomes Research
ClinicoEconomics and Outcomes Research
- View all (518)
- Volume 11, 2019 (30)
- Volume 10, 2018 (77)
- Volume 9, 2017 (77)
- Volume 8, 2016 (73)
- Volume 7, 2015 (64)
- Volume 6, 2014 (53)
- Volume 5, 2013 (59)
- Volume 4, 2012 (41)
- Volume 3, 2011 (19)
- Volume 2, 2010 (16)
- Volume 1, 2009 (9)
Journal Articles:
- 518 records -
Budget impact model of avelumab in patients with metastatic merkel cell carcinoma in the US
Bharmal M, Kearney M, Zheng Y, Phatak H
ClinicoEconomics and Outcomes Research 2019, 11:349-359
Published Date: 22 May 2019
An iron triangle ROI model for health care
van der Goes DN, Edwardson N, Rayamajhee V, Hollis C, Hunter D
ClinicoEconomics and Outcomes Research 2019, 11:335-348
Published Date: 10 May 2019
Electronic referral systems in health care: a scoping review
Azamar-Alonso A, Costa AP, Huebner LA, Tarride JE
ClinicoEconomics and Outcomes Research 2019, 11:325-333
Published Date: 6 May 2019
The impact of increased post-progression survival on the cost-effectiveness of interventions in oncology
Retzler J, Davies H, Jenks M, Kiff C, Taylor M
ClinicoEconomics and Outcomes Research 2019, 11:309-324
Published Date: 3 May 2019
Cost-effectiveness of fractional exhaled nitric oxide (FeNO) measurement in predicting response to omalizumab in asthma
Brooks EA, Massanari M, Hanania NA, Weiner DJ
ClinicoEconomics and Outcomes Research 2019, 11:301-307
Published Date: 17 April 2019
HTA and innovative treatments evaluation: the case of metastatic castration-resistant prostate cancer
Bretoni A, Ferrario L, Foglia E
ClinicoEconomics and Outcomes Research 2019, 11:283-300
Published Date: 17 April 2019
Cost of achieving HbA1c and weight loss treatment targets with IDegLira vs insulin glargine U100 plus insulin aspart in the USA
Billings LK, Mocarski M, Basse A, Hunt B, Valentine WJ, Jodar E
ClinicoEconomics and Outcomes Research 2019, 11:271-282
Published Date: 21 March 2019
Cost-effectiveness model for a hypothetical monotherapy vs standard of care in adult patients with treatment-resistant depression
Wang ST, Anderson IM, Mitchell D, Johnson SJ, Shiozawa A
ClinicoEconomics and Outcomes Research 2019, 11:257-270
Published Date: 14 March 2019
Cost-of-illness of knee osteoarthritis: potential cost savings by not undergoing arthroplasty within the first 2 years
Ong KL, Runa M, Lau E, Altman RD
ClinicoEconomics and Outcomes Research 2019, 11:245-255
Published Date: 14 March 2019
Health-related quality of life outcomes, economic burden, and associated costs among diagnosed and undiagnosed depression patients in Japan
Yamabe K, Liebert R, Flores N, Pashos CL
ClinicoEconomics and Outcomes Research 2019, 11:233-243
Published Date: 12 March 2019
Health-related quality of life outcomes and economic burden of inflammatory bowel disease in Japan
Yamabe K, Liebert R, Flores N, Pashos CL
ClinicoEconomics and Outcomes Research 2019, 11:221-232
Published Date: 12 March 2019
Relative value assessment: characterizing the benefit of oncology therapies through diverse survival metrics from a US perspective
Macaulay R, Ahuja A, Ademisoye E, Juarez-Garcia A, Shaw JW
ClinicoEconomics and Outcomes Research 2019, 11:199-219
Published Date: 19 March 2019
Reduction of direct costs in high-risk lumbar discectomy patients during the 90-day post-operative period through annular closure
Thaci B, McGirt MJ, Ammerman JM, Thomé C, Kim KD, Ament JD
ClinicoEconomics and Outcomes Research 2019, 11:191-197
Published Date: 28 February 2019
Health care utilization and costs following amplified versus non-amplified molecular probe testing for symptomatic patients with suspected vulvovaginitis: a US commercial payer population
Ackerman SJ, Knight T, Wahl PM, Cartwright CP
ClinicoEconomics and Outcomes Research 2019, 11:179-189
Published Date: 20 February 2019
A cost-consequence analysis of parecoxib and opioids vs opioids alone for postoperative pain: Chinese perspective
Barra M, Remák E, Liu DD, Xie L, Abraham L, Sadosky AB
ClinicoEconomics and Outcomes Research 2019, 11:169-177
Published Date: 22 February 2019
Cost-effectiveness of secukinumab compared to other biologics in the treatment of ankylosing spondylitis in Finland
Purmonen T, Puolakka K, Mishra D, Gunda P, Martikainen J
ClinicoEconomics and Outcomes Research 2019, 11:159-168
Published Date: 15 February 2019
Catastrophic health expenditure of Vietnamese patients with gallstone diseases – a case for health insurance policy revaluation
Tran BX, Tran TD, Nathan N, Ngo CQ, Nguyen LT, Nguyen LH, Nguyen HLT, Nguyen CT, Do HP, Nguyen THT, Tran TT, Thai TPT, Dang AK, Nguyen NB, Latkin CA, Ho CSH, Ho RCM
ClinicoEconomics and Outcomes Research 2019, 11:151-158
Published Date: 11 February 2019
Ninety-day postoperative cost in primary total hip arthroplasty: an economic model comparing surgical approaches
Miller LE, Martinson MS, Gondusky JS, Kamath AF, Boettner F, Bhattacharyya SK
ClinicoEconomics and Outcomes Research 2019, 11:145-149
Published Date: 7 February 2019
Length of stay, mortality, and readmissions among Medicare cancer patients treated with glucarpidase and conventional care: a retrospective study
Demiralp B, Koenig L, Kala J, Feng C, Hamlett EG, Steele-Adjognon M, Ward S
ClinicoEconomics and Outcomes Research 2019, 11:129-144
Published Date: 7 February 2019
Sarilumab monotherapy compared with adalimumab monotherapy for the treatment of moderately to severely active rheumatoid arthritis: an analysis of incremental cost per effectively treated patient
Fournier M, Chen C, Kuznik A, Proudfoot C, Mallya UG, Michaud K
ClinicoEconomics and Outcomes Research 2019, 11:117-128
Published Date: 5 February 2019
Economic impact of pharmacist interventions on correction of stress-related mucosal damage prophylaxis practice
Mahmoudi L, Mohammadi R, Niknam R
ClinicoEconomics and Outcomes Research 2019, 11:111-116
Published Date: 25 January 2019
Comparative analysis of US real-world dosing patterns and direct infusion-related costs for matched cohorts of rheumatoid arthritis patients treated with infliximab or intravenous golimumab
Ellis LA, Malangone-Monaco E, Varker H, Stetsovsky D, Kubacki M, DeHoratius RJ, Kafka S
ClinicoEconomics and Outcomes Research 2019, 11:99-110
Published Date: 15 January 2019
Health-related quality of life in acute myeloid leukemia patients not eligible for intensive chemotherapy: results of a systematic literature review
Forsythe A, Kwon CS, Bell T, Smith TA, Arondekar B
ClinicoEconomics and Outcomes Research 2019, 11:87-98
Published Date: 14 January 2019
Budget impact analysis of sarilumab for the treatment of rheumatoid arthritis in patients with an inadequate response to conventional synthetic DMARD or TNF inhibitor therapies [Corrigendum]
Ferrufino CP, Munakata J, Wei W, Proudfoot C, Kuznik A, Boklage SH, Chen C
ClinicoEconomics and Outcomes Research 2019, 11:83-85
Published Date: 14 January 2019
Cost-effectiveness of sensor-augmented insulin pump therapy vs continuous subcutaneous insulin infusion in patients with type 1 diabetes in the Netherlands
Roze S, Smith-Palmer J, de Portu S, Dalbaere A, de Brouwer B, de Valk HW
ClinicoEconomics and Outcomes Research 2019, 11:73-82
Published Date: 14 January 2019
Health-related outcomes, health care resource utilization, and costs of multiple sclerosis in Japan compared with US and five EU countries
Yamabe K, DiBonaventura MD, Pashos CL
ClinicoEconomics and Outcomes Research 2019, 11:61-71
Published Date: 7 January 2019
Impact of migraine on health care utilization and expenses in obese adults: a US population-based study
Wu J, Davis-Ajami ML, Lu ZK
ClinicoEconomics and Outcomes Research 2019, 11:51-59
Published Date: 31 December 2018
Systematic literature review of treatment patterns for venous thromboembolism patients during transitions from inpatient to post-discharge settings
Trocio J, Rosen VM, Gupta A, Dina O, Vo L, Hlavacek P, Rosenblatt L
ClinicoEconomics and Outcomes Research 2019, 11:23-49
Published Date: 19 December 2018
Indirect costs associated with premature mortality among those with veno-occlusive disease/sinusoidal obstruction syndrome with multiorgan dysfunction post-hematopoietic stem-cell-transplant
Zhou ZY, Tang W, Villa KF
ClinicoEconomics and Outcomes Research 2019, 11:13-22
Published Date: 17 December 2018
A US hospital budget impact analysis of a skin closure system compared with standard of care in hip and knee arthroplasty
Sadik K, Flener J, Gargiulo J, Post Z, Wurzelbacher S, Hogan A, Hollmann S, Ferko N
ClinicoEconomics and Outcomes Research 2019, 11:1-11
Published Date: 17 December 2018
The number needed to treat and relevant between-trial comparisons of competing interventions
Jansen JP, Khalid JM, Smyth MD, Patel H
ClinicoEconomics and Outcomes Research 2018, 10:865-871
Published Date: 14 December 2018
The cost impact to Medicare of shifting treatment of worsening heart failure from inpatient to outpatient management settings
Fitch K, Lau J, Engel T, Medicis JJ, Mohr JF, Weintraub WS
ClinicoEconomics and Outcomes Research 2018, 10:855-863
Published Date: 14 December 2018
A methodological review of national and transnational pharmaceutical budget impact analysis guidelines for new drug submissions
Foroutan N, Tarride JE, Xie F, Levine M
ClinicoEconomics and Outcomes Research 2018, 10:821-854
Published Date: 26 November 2018
Budget impact analysis of sarilumab for the treatment of rheumatoid arthritis in patients with an inadequate response to conventional synthetic DMARD or TNF inhibitor therapies
Ferrufino CP, Munakata J, Wei W, Proudfoot C, Kuznik A, Boklage SH, Chen C
ClinicoEconomics and Outcomes Research 2018, 10:805-819
Published Date: 16 November 2018
Cost-effectiveness and budget impact of liraglutide in type 2 diabetes patients with elevated cardiovascular risk: a US-managed care perspective
Shah D, Risebrough NA, Perdrizet J, Iyer NN, Gamble C, Dang-Tan T
ClinicoEconomics and Outcomes Research 2018, 10:791-803
Published Date: 14 November 2018
Cost-effectiveness analysis of ribociclib versus palbociclib in the first-line treatment of HR+/HER2– advanced or metastatic breast cancer in Spain
Galve-Calvo E, González-Haba E, Gostkorzewicz J, Martínez I, Pérez-Mitru A
ClinicoEconomics and Outcomes Research 2018, 10:773-790
Published Date: 14 November 2018
Impact of postcolectomy adhesion-related complications on healthcare utilization
Etter K, Sutton N, Wei D, Yoo A
ClinicoEconomics and Outcomes Research 2018, 10:761-771
Published Date: 14 November 2018
Cost effectiveness of ixekizumab versus secukinumab in the treatment of moderate-to-severe plaque psoriasis in Spain
Johansson E, Nuñez M, Svedbom A, Dilla T, Hartz S
ClinicoEconomics and Outcomes Research 2018, 10:747-759
Published Date: 12 November 2018
Cost-utility of surgical sutureless bioprostheses vs TAVI in aortic valve replacement for patients at intermediate and high surgical risk
Povero M, Miceli A, Pradelli L, Ferrarini M, Pinciroli M, Glauber M
ClinicoEconomics and Outcomes Research 2018, 10:733-745
Published Date: 8 November 2018
Impact of comorbidity on the risk and cost of hospitalization in HIV-infected patients: real-world data from Abruzzo Region [Corrigendum]
Cammarota S, Citarella A, Manzoli L, Flacco ME, Parruti G
ClinicoEconomics and Outcomes Research 2018, 10:731-732
Published Date: 8 November 2018
Multiple sclerosis patients who are stable on interferon therapy show better outcomes when staying on same therapy than patients who switch to another interferon
Chen C, Wu N, Watson C
ClinicoEconomics and Outcomes Research 2018, 10:723-730
Published Date: 2 November 2018
Cost-consequence model comparing eltrombopag and romiplostim in pediatric patients with chronic immune thrombocytopenia
Tremblay G, Dolph M, Bhor M, Said Q, Roy A, Elliott B, Briggs A
ClinicoEconomics and Outcomes Research 2018, 10:715-721
Published Date: 5 November 2018
Cost-consequence model comparing eltrombopag versus romiplostim for adult patients with chronic immune thrombocytopenia
Tremblay G, Dolph M, Bhor M, Said Q, Elliott B, Briggs A
ClinicoEconomics and Outcomes Research 2018, 10:705-713
Published Date: 1 November 2018
Incremental health care resource utilization and expenditures associated with autosomal dominant polycystic kidney disease
Iyer NN, Vendetti NJ, Levy DI, Mardekian J, Mychaskiw MA, Thomas III J
ClinicoEconomics and Outcomes Research 2018, 10:693-703
Published Date: 31 October 2018
Burden of cancer pain in developing countries: a narrative literature review
Li Z, Aninditha T, Griene B, Francis J, Renato P, Serrie A, Umareddy I, Boisseau S, Hadjiat Y
ClinicoEconomics and Outcomes Research 2018, 10:675-691
Published Date: 2 November 2018
Economic benefits of implementing patient-centered medical home among patients with hypertension
Almalki ZS, Alotaibi AA, Alzaidi WS, Alghamdi AA, Bahowirth AM, Alsalamah NM
ClinicoEconomics and Outcomes Research 2018, 10:665-673
Published Date: 31 October 2018
Economic analysis of pharmacist-administered influenza vaccines in Ontario, Canada
O'Reilly DJ, Blackhouse G, Burns S, Bowen JM, Burke N, Mehltretter J, Waite NM, Houle SKD
ClinicoEconomics and Outcomes Research 2018, 10:655-663
Published Date: 24 October 2018
Health-related outcomes and economic burden in Japan: focus on inflammatory bowel disease, multiple sclerosis, and depression
Yamabe K
ClinicoEconomics and Outcomes Research 2018, 10:653-654
Published Date: 23 October 2018
Sacroiliac joint fusion health care cost comparison prior to and following surgery: an administrative claims analysis
Buysman EK, Halpern R, Polly DW
ClinicoEconomics and Outcomes Research 2018, 10:643-651
Published Date: 17 October 2018
Real-world analysis of cost, health care resource utilization, and supportive care in Hodgkin lymphoma patients with frontline failure
Bonafede M, Feliciano J, Cai Q, Noxon V, Princic N, Richhariya A, Straus DJ
ClinicoEconomics and Outcomes Research 2018, 10:629-641
Published Date: 17 October 2018
Impact of antiepileptic-drug treatment burden on health-care-resource utilization and costs
Rajagopalan K, Candrilli SD, Ajmera M
ClinicoEconomics and Outcomes Research 2018, 10:619-627
Published Date: 16 October 2018
The role of a best practice alert in the electronic medical record in reducing repetitive lab tests
Bejjanki H, Mramba LK, Beal SG, Radhakrishnan N, Bishnoi R, Shah C, Agrawal N, Harris N, Leverence R, Rand K
ClinicoEconomics and Outcomes Research 2018, 10:611-618
Published Date: 8 October 2018
A single blind, multicenter, randomized controlled trial to evaluate the effectiveness and cost of a novel nutraceutical (LopiGLIK®) lowering cardiovascular disease risk
Manfrin A, Trimarco V, Manzi MV, Rozza F, Izzo R
ClinicoEconomics and Outcomes Research 2018, 10:601-609
Published Date: 8 October 2018
Comparison of real-world clinical and economic outcomes between the ThermoCool® SF and ThermoCool® catheters in patients undergoing radiofrequency catheter ablation for atrial fibrillation
Chinitz L, Goldstein LJ, Barnow A, Maccioni S, Daskiran M, Kalsekar I, Khanna R
ClinicoEconomics and Outcomes Research 2018, 10:587-599
Published Date: 4 October 2018
Does knowledge of patient non-compliance change prescribing behavior in the real world? A claims-based analysis of patients with serious mental illness
Shafrin J, Bognar K, Everson K, Brauer M, Lakdawalla DN, Forma FM
ClinicoEconomics and Outcomes Research 2018, 10:573-585
Published Date: 2 October 2018
Societal costs due to meningococcal disease: a national registry-based study
Gustafsson N, Stallknecht SE, Skovdal M, Poulsen PB, Østergaard L
ClinicoEconomics and Outcomes Research 2018, 10:563-572
Published Date: 2 October 2018
Impact of a pharmacist-led diabetes management on outcomes, utilization, and cost
Maeng DD, Graham J, Bogart M, Hao J, Wright EA
ClinicoEconomics and Outcomes Research 2018, 10:551-562
Published Date: 24 September 2018
Cost-effectiveness analysis of treatment timing considering the future entry of lower-cost generics for hepatitis C
Heath K
ClinicoEconomics and Outcomes Research 2018, 10:539-550
Published Date: 20 September 2018
Cost of acute cough in Italian children
Dal Negro RW, Turco P, Povero M
ClinicoEconomics and Outcomes Research 2018, 10:529-537
Published Date: 17 September 2018
Propensity score matching comparison of laparoscopic versus open surgery for rectal cancer in a middle-income country: short-term outcomes and cost analysis
Tayar DO, Ribeiro Jr U, Cecconello I, Magalhães TM, Simões CM, Auler Jr JOC
ClinicoEconomics and Outcomes Research 2018, 10:521-527
Published Date: 12 September 2018
Cost-effectiveness analysis of voriconazole, fluconazole, and amphotericin B for invasive fungal infections following allogeneic hematopoietic stem cell transplantation in Mexico
Morfín-Otero R, Alvarado-Ibarra M, Rodriguez-Noriega E, Resendiz-Sanchez J, Patel DA, Stephens JM, Di Fusco M, Mendoza CF, Charbonneau C
ClinicoEconomics and Outcomes Research 2018, 10:511-520
Published Date: 6 September 2018
Cost–consequence analysis of fluticasone furoate/vilanterol 92/22 mcg for the management of COPD in the Spanish NHS
Vallejo-Aparicio LA, Peces-Barba G, Gil A, Huerta Hernandez A
ClinicoEconomics and Outcomes Research 2018, 10:501-510
Published Date: 5 September 2018
Incidence of febrile neutropenia during chemotherapy among patients with nonmyeloid cancer receiving filgrastim vs a filgrastim biosimilar
Schwartzberg LS, Lal LS, Balu S, Campbell K, Brekke L, Elliott C, Korrer S
ClinicoEconomics and Outcomes Research 2018, 10:493-500
Published Date: 3 September 2018
Budget impact model of secukinumab for the treatment of moderate-to-severe psoriasis, psoriatic arthritis, and ankylosing spondylitis in Italy: a cross-indication initiative
Colombo GL, Di Matteo S, Martinotti C, Jugl SM, Gunda P, Naclerio M, Bruno GM
ClinicoEconomics and Outcomes Research 2018, 10:477-491
Published Date: 30 August 2018
Obesity in Germany and Italy: prevalence, comorbidities, and associations with patient outcomes
DiBonaventura M, Nicolucci A, Meincke H, Le Lay A, Fournier J
ClinicoEconomics and Outcomes Research 2018, 10:457-475
Published Date: 24 August 2018
Relapse prevention: a cost-effectiveness analysis of brexpiprazole treatment in adult patients with schizophrenia in the USA
Aigbogun MS, Liu S, Kamat SA, Sapin C, Duhig AM, Citrome L
ClinicoEconomics and Outcomes Research 2018, 10:443-456
Published Date: 16 August 2018
Cost of opioid medication abuse with and without tampering in the USA
Vietri J, Masters ET, Barsdorf AI, Mardekian J
ClinicoEconomics and Outcomes Research 2018, 10:433-442
Published Date: 10 August 2018
The burden of cystic fibrosis in the Medicaid population
Hassan M, Bonafede MM, Limone BL, Hodgkins P, Sawicki GS
ClinicoEconomics and Outcomes Research 2018, 10:423-431
Published Date: 25 July 2018
Cost-minimization analysis of degludec/liraglutide versus glargine/aspart: economic implications of the DUAL VII study outcomes
Torre E, Bruno GM, Di Matteo S, Martinotti C, Oselin M, Valentino MC, Parodi A, Bottaro LC, Colombo GL
ClinicoEconomics and Outcomes Research 2018, 10:413-421
Published Date: 26 July 2018
Procedure costs associated with the use of Harmonic devices compared to conventional techniques in various surgeries: a systematic review and meta-analysis
Cheng H, Clymer JW, Qadeer RA, Ferko N, Sadeghirad B, Cameron CG, Amaral JF
ClinicoEconomics and Outcomes Research 2018, 10:399-412
Published Date: 24 July 2018
Impact of comorbidity on the risk and cost of hospitalization in HIV-infected patients: real-world data from Abruzzo Region
Cammarota S, Citarella A, Manzoli L, Flacco ME, Parruti G
ClinicoEconomics and Outcomes Research 2018, 10:389-398
Published Date: 23 July 2018
Health-care utilization and outcomes of patients at high risk of invasive fungal infection
Fu R, Gundrum J, Sung AH
ClinicoEconomics and Outcomes Research 2018, 10:371-387
Published Date: 12 July 2018
A cost–benefit analysis of smoking cessation prescription coverage from a US payer perspective
Baker CL, Ding Y, Ferrufino CP, Kowal S, Tan J, Subedi P
ClinicoEconomics and Outcomes Research 2018, 10:359-370
Published Date: 16 July 2018
Post-lumbar discectomy reoperations that are associated with poor clinical and socioeconomic outcomes can be reduced through use of a novel annular closure device: results from a 2-year randomized controlled trial
Klassen PD, Hsu WK, Martens F, Inzana JA, van den Brink WA, Groff MW, Thomé C
ClinicoEconomics and Outcomes Research 2018, 10:349-357
Published Date: 26 June 2018
Evaluation of statin utilization in the Republic of Macedonia during 2013–2016
Naumovska Z, Nestorovska AK, Grozdanova A, Hristova K, Dimovski A, Suturkova L, Sterjev Z
ClinicoEconomics and Outcomes Research 2018, 10:339-347
Published Date: 26 June 2018
Cost-effectiveness analysis of treating transplant-eligible multiple myeloma patients in Macedonia
Qerimi V, Kapedanovska Nestorovska A, Sterjev Z, Genadieva-Stavric S, Suturkova L
ClinicoEconomics and Outcomes Research 2018, 10:327-338
Published Date: 20 June 2018
The cost of dysphagia in geriatric patients
Westmark S, Melgaard D, Rethmeier LO, Ehlers LH
ClinicoEconomics and Outcomes Research 2018, 10:321-326
Published Date: 6 June 2018
A systematic literature review of the clinical and health economic burden of schizophrenia in privately insured patients in the United States
Zhang W, Amos TB, Gutkin SW, Lodowski N, Giegerich E, Joshi K
ClinicoEconomics and Outcomes Research 2018, 10:309-320
Published Date: 8 June 2018
A comparison between WHODAS 2.0 and Modified Barthel Index: which tool is more suitable for assessing the disability and the recovery rate in orthopedic rehabilitation?
Galli T, Mirata P, Foglia E, Croce D, Porazzi E, Ferrario L, Ricci E, Garagiola E, Pagani R, Banfi G
ClinicoEconomics and Outcomes Research 2018, 10:301-307
Published Date: 5 June 2018
Early introduction of a semi-elemental formula may be cost saving compared to a polymeric formula among critically ill patients requiring enteral nutrition: a cohort cost–consequence model
Curry AS, Chadda S, Danel A, Nguyen DL
ClinicoEconomics and Outcomes Research 2018, 10:293-300
Published Date: 5 June 2018
Cost-effectiveness of pulse-echo ultrasonometry in osteoporosis management
Soini E, Riekkinen O, Kröger H, Mankinen P, Hallinen T, Karjalainen JP
ClinicoEconomics and Outcomes Research 2018, 10:279-292
Published Date: 29 May 2018
Economic evaluation of point-of-care testing in the remote primary health care setting of Australia’s Northern Territory
Spaeth BA, Kaambwa B, Shephard MDS, Omond R
ClinicoEconomics and Outcomes Research 2018, 10:269-277
Published Date: 29 May 2018
Claims-based proxies of patient instability among commercially insured adults with schizophrenia
Ruetsch C, Un H, Waters HC
ClinicoEconomics and Outcomes Research 2018, 10:259-267
Published Date: 7 May 2018
Prevalence of antibiotic prescription in southern Italian outpatients: real-world data analysis of socioeconomic and sociodemographic variables at a municipality level
Russo V, Monetti VM, Guerriero F, Trama U, Guida A, Menditto E, Orlando V
ClinicoEconomics and Outcomes Research 2018, 10:251-258
Published Date: 3 May 2018
Cost-effectiveness comparison of cabozantinib with everolimus, axitinib, and nivolumab in the treatment of advanced renal cell carcinoma following the failure of prior therapy in England
Meng J, Lister J, Vataire AL, Casciano R, Dinet J
ClinicoEconomics and Outcomes Research 2018, 10:243-250
Published Date: 23 April 2018
Intermittent pneumatic compression is a cost-effective method of orthopedic postsurgical venous thromboembolism prophylaxis
Saunders R, Comerota AJ, Ozols A, Torrejon Torres R, Ho KM
ClinicoEconomics and Outcomes Research 2018, 10:231-241
Published Date: 19 April 2018
An evaluation of the budget impact of a new 20% subcutaneous immunoglobulin (Ig20Gly) for the management of primary immunodeficiency diseases in Switzerland
Pollock RF, Meckley LM
ClinicoEconomics and Outcomes Research 2018, 10:223-229
Published Date: 10 April 2018
The economic and clinical burden of early versus late initiation of celecoxib among patients with osteoarthritis
Shelbaya A, Solem CT, Walker C, Wan Y, Johnson C, Cappelleri JC
ClinicoEconomics and Outcomes Research 2018, 10:213-222
Published Date: 6 April 2018
Clinical outcomes and health care utilization pre- and post-laparoscopic radiofrequency ablation of symptomatic fibroids and laparoscopic myomectomy: a randomized trial of uterine-sparing techniques (TRUST) in Canada
Rattray DD, Weins L, Regush LC, Bowen JM, O'Reilly D, Thiel JA
ClinicoEconomics and Outcomes Research 2018, 10:201-212
Published Date: 5 April 2018
Clinical and economic impact of the 21-gene recurrence score assay in adjuvant therapy decision making in patients with early-stage breast cancer: pooled analysis in 4 Basque Country university hospitals
Martínez del Prado P, Alvarez-López I, Domínguez-Fernández S, Plazaola A, Ibarrondo O, Galve-Calvo E, Ancizar-Lizarraga N, Gutierrez-Toribio M, Lahuerta-Martínez A, Mar J
ClinicoEconomics and Outcomes Research 2018, 10:189-199
Published Date: 19 March 2018
Cost analysis of a growth guidance system compared with traditional and magnetically controlled growing rods for early-onset scoliosis: a US-based integrated health care delivery system perspective
Luhmann SJ, McAughey EM, Ackerman SJ, Bumpass DB, McCarthy RE
ClinicoEconomics and Outcomes Research 2018, 10:179-187
Published Date: 16 March 2018
Cost utility, budget impact, and scenario analysis of racecadotril in addition to oral rehydration for acute diarrhea in children in Malaysia
Rautenberg TA, Zerwes U, Lee WS
ClinicoEconomics and Outcomes Research 2018, 10:169-178
Published Date: 15 March 2018
Analysis of utilization patterns and associated costs of the breast imaging and diagnostic procedures after screening mammography
Vlahiotis A, Griffin B, Stavros AT, Margolis J
ClinicoEconomics and Outcomes Research 2018, 10:157-167
Published Date: 26 March 2018
Cost analysis of pulmonary lobectomy procedure: comparison of stapler versus precision dissection and sealant [Corrigendum]
Droghetti A, Marulli G, Vannucci J, Giovanardi M, Bottoli MC, Ragusa M, Muriana G
ClinicoEconomics and Outcomes Research 2018, 10:155-156
Published Date: 13 March 2018
Modeling the economic outcomes of immuno-oncology drugs: alternative model frameworks to capture clinical outcomes
Gibson EJ, Begum N, Koblbauer I, Dranitsaris G, Liew D, McEwan P, Tahami Monfared AA, Yuan Y, Juarez-Garcia A, Tyas D, Lees M
ClinicoEconomics and Outcomes Research 2018, 10:139-154
Published Date: 8 March 2018
Clinical and economic burden of idiopathic pulmonary fibrosis in Quebec, Canada
Tarride JE, Hopkins RB, Burke N, Guertin JR, O'Reilly D, Fell CD, Dion G, Kolb M
ClinicoEconomics and Outcomes Research 2018, 10:127-137
Published Date: 22 February 2018
Early laparoscopic cholecystectomy is more cost-effective than delayed laparoscopic cholecystectomy in the treatment of acute cholecystitis
Kerwat D, Zargaran A, Bharamgoudar R, Arif N, Bello G, Sharma B, Kerwat R
ClinicoEconomics and Outcomes Research 2018, 10:119-125
Published Date: 19 February 2018
A cost-utility analysis of small bite sutures versus large bite sutures in the closure of midline laparotomies in the United Kingdom National Health Service
Gokani SA, Elmqvist KO, El-Koubani O, Ash J, Biswas SK, Rigaudy M
ClinicoEconomics and Outcomes Research 2018, 10:105-117
Published Date: 19 February 2018
Oral versus intravenous iron therapy in patients with inflammatory bowel disease and iron deficiency with and without anemia in Germany – a real-world evidence analysis
Stein J, Haas JS, Ong SH, Borchert K, Hardt T, Lechat E, Nip K, Foerster D, Braun S, Baumgart DC
ClinicoEconomics and Outcomes Research 2018, 10:93-103
Published Date: 5 February 2018
Systematic review of health state utility values for acute myeloid leukemia
Forsythe A, Brandt PS, Dolph M, Patel S, Rabe APJ, Tremblay G
ClinicoEconomics and Outcomes Research 2018, 10:83-92
Published Date: 25 January 2018
The preventive effect on respiratory tract infections of Oscillococcinum®. A cost-effectiveness analysis
Colombo GL, Di Matteo S, Martinotti C, Oselin M, Bruno GM, Beghi GM
ClinicoEconomics and Outcomes Research 2018, 10:75-82
Published Date: 23 January 2018
A cost-effectiveness analysis of varenicline for smoking cessation using data from the EAGLES trial
Baker CL, Pietri G
ClinicoEconomics and Outcomes Research 2018, 10:67-74
Published Date: 19 January 2018
Pain associated with health and economic burden in France: results from recent National Health and Wellness Survey data
Hadjiat Y, Serrie A, Treves R, Chomier B, Geranton L, Billon S
ClinicoEconomics and Outcomes Research 2018, 10:53-65
Published Date: 18 January 2018
Economic evaluation of spondyloarthritis: economic impact of diagnostic delay in Italy
Mennini FS, Viti R, Marcellusi A, Sciattella P, Viapiana O, Rossini M
ClinicoEconomics and Outcomes Research 2018, 10:45-51
Published Date: 10 January 2018
Cost-effectiveness analysis of six therapies for the treatment of lower urinary tract symptoms due to benign prostatic hyperplasia
Ulchaker JC, Martinson MS
ClinicoEconomics and Outcomes Research 2018, 10:29-43
Published Date: 29 December 2017
Epidemiology, associated burden, and current clinical practice for the diagnosis and management of Alzheimer’s disease in Japan
Montgomery W, Ueda K, Jorgensen M, Stathis S, Cheng Y, Nakamura T
ClinicoEconomics and Outcomes Research 2018, 10:13-28
Published Date: 28 December 2017
Clinical and economic outcomes of a "high-touch" clinical management program for intravenous immunoglobulin therapy
Zhu J, Kirkham HS, Ayer G, Chen CC, Wade RL, Karkare SU, Robson CH, Orange JS
ClinicoEconomics and Outcomes Research 2018, 10:1-12
Published Date: 19 December 2017
"De-escalation" strategy using micafungin for the treatment of systemic Candida infections: budget impact in France and Germany
van Engen A, Casamayor M, Kim S, Watt M, Odeyemi I
ClinicoEconomics and Outcomes Research 2017, 9:763-774
Published Date: 5 December 2017
Cost-effectiveness analysis of IDegLira versus basal-bolus insulin for patients with type 2 diabetes in the Slovak health system
Psota M, Psenkova MB, Racekova N, Ramirez de Arellano A, Vandebrouck T, Hunt B
ClinicoEconomics and Outcomes Research 2017, 9:749-762
Published Date: 12 December 2017
Biological therapy utilization, switching, and cost among patients with psoriasis: retrospective analysis of administrative databases in Southern Italy
Guerriero F, Orlando V, Monetti VM, Russo V, Menditto E
ClinicoEconomics and Outcomes Research 2017, 9:741-748
Published Date: 1 December 2017
Early intervention in the management of pulmonary arterial hypertension: clinical and economic outcomes
Burger CD, Ghandour M, Padmanabhan Menon D, Helmi H, Benza RL
ClinicoEconomics and Outcomes Research 2017, 9:731-739
Published Date: 24 November 2017
Do reimbursement recommendation processes used by government drug plans in Canada adhere to good governance principles?
Rawson NS, Adams J
ClinicoEconomics and Outcomes Research 2017, 9:721-730
Published Date: 22 November 2017
Estimating the risk of severe hypoglycemic event related to glucose-lowering treatment among Italian patients with diabetes: the HYPOTHESIS database
Mazzi S, Ravasio R, Forlani G, Veronese G, Fabbri A, Marchesini G
ClinicoEconomics and Outcomes Research 2017, 9:711-720
Published Date: 21 November 2017
Cost-consequence analysis of sitagliptin versus sulfonylureas as add-on therapy for the treatment of diabetic patients in Italy
Lorenzoni V, Baccetti F, Genovese S, Torre E, Turchetti G
ClinicoEconomics and Outcomes Research 2017, 9:699-710
Published Date: 20 November 2017
Propofol or benzodiazepines for short- and long-term sedation in intensive care units? An economic evaluation based on meta-analytic results
Pradelli L, Povero M, Bürkle H, Kampmeier T, Della-Rocca G, Feuersenger A, Baron J, Westphal M
ClinicoEconomics and Outcomes Research 2017, 9:685-698
Published Date: 9 November 2017
A comparative analysis of clinical outcomes and disposable costs of different catheter ablation methods for the treatment of atrioventricular nodal reentrant tachycardia
Berman AE, Rivner H, Chalkley R, Heboyan V
ClinicoEconomics and Outcomes Research 2017, 9:677-683
Published Date: 6 November 2017
Repeated intermittent ulipristal acetate in the treatment of uterine fibroids: a cost-effectiveness analysis
Geale K, Saridogan E, Lehmann M, Arriagada P, Hultberg M, Henriksson M
ClinicoEconomics and Outcomes Research 2017, 9:669-676
Published Date: 1 November 2017
Evaluating the cost-effectiveness of afatinib after platinum-based therapy for the treatment of squamous non-small-cell lung cancer in France
Pignata M, Chouaid C, Le Lay K, Luciani L, McConnachie C, Gordon J, Roze S
ClinicoEconomics and Outcomes Research 2017, 9:655-668
Published Date: 25 October 2017
Burden of uterine fibroids in Italy: epidemiology, treatment outcomes, and consumption of health care resources in more than 5,000 women [Corrigendum]
Chiumente M, De Rosa M, Messori A, Proli EM
ClinicoEconomics and Outcomes Research 2017, 9:653-654
Published Date: 17 October 2017
Cost-effectiveness of vedolizumab compared with conventional therapy for ulcerative colitis patients in the UK
Wilson MR, Azzabi Zouraq I, Chevrou-Severac H, Selby R, Kerrigan MC
ClinicoEconomics and Outcomes Research 2017, 9:641-652
Published Date: 16 October 2017
Predictors of reaching a serum uric acid goal in patients with gout and treated with febuxostat
Sheer R, Null KD, Szymanski KA, Sudharshan L, Banovic J, Pasquale MK
ClinicoEconomics and Outcomes Research 2017, 9:629-639
Published Date: 10 October 2017
Setting priorities in the health care sector – the case of oral anticoagulants in nonvalvular atrial fibrillation in Denmark
Poulsen PB, Johnsen SP, Hansen ML, Brandes A, Husted S, Harboe L, Dybro L
ClinicoEconomics and Outcomes Research 2017, 9:617-627
Published Date: 10 October 2017
Epidemiology, patient profile, and health care resource use for hepatitis C in Italy
Sangiorgi D, Perrone V, Buda S, Boglione L, Cariti G, Lefevre C, Nappi C, Degli Esposti L
ClinicoEconomics and Outcomes Research 2017, 9:609-616
Published Date: 10 October 2017
The cost of successful antiviral therapy in hepatitis C patients: a comparison of IFN-free versus IFN-based regimens at an individual patient level in Australia
Lee AS, van Driel ML, Crawford DHG
ClinicoEconomics and Outcomes Research 2017, 9:595-607
Published Date: 3 October 2017
Utilization of fetal fibronectin testing and pregnancy outcomes among women with symptoms of preterm labor
Blackwell SC, Sullivan EM, Petrilla AA, Shen X, Troeger KA, Byrne JD
ClinicoEconomics and Outcomes Research 2017, 9:585-594
Published Date: 3 October 2017
Drug tendering: drug supply and shortage implications for the uptake of biosimilars
Dranitsaris G, Jacobs I, Kirchhoff C, Popovian R, Shane LG
ClinicoEconomics and Outcomes Research 2017, 9:573-584
Published Date: 29 September 2017
Update of the budget impact analysis of the simplification to atazanavir + ritonavir + lamivudine dual therapy of HIV-positive patients receiving atazanavir-based triple therapies in Italy starting from data of the Atlas-M trial
Restelli U, Fabbiani M, Di Giambenedetto S, Nappi C, Croce D
ClinicoEconomics and Outcomes Research 2017, 9:569-571
Published Date: 27 September 2017
Cost-effectiveness analysis of intravenous ferumoxytol for the treatment of iron deficiency anemia in adult patients with non-dialysis-dependent chronic kidney disease in the USA
Dahl NV, Kaper RF, Strauss WE, Corvino FA, Zivkovic M
ClinicoEconomics and Outcomes Research 2017, 9:557-567
Published Date: 20 September 2017
Parenteral nutrition including an omega-3 fatty-acid-containing lipid emulsion for intensive care patients in China: a pharmacoeconomic analysis
Feng Y, Li C, Zhang T, Pradelli L
ClinicoEconomics and Outcomes Research 2017, 9:547-555
Published Date: 5 September 2017
Current recommendations on the estimation of transition probabilities in Markov cohort models for use in health care decision-making: a targeted literature review
Olariu E, Cadwell KK, Hancock E, Trueman D, Chevrou-Severac H
ClinicoEconomics and Outcomes Research 2017, 9:537-546
Published Date: 1 September 2017
Burden of uterine fibroids in Italy: epidemiology, treatment outcomes, and consumption of health care resources in more than 5,000 women
Chiumente M, De Rosa M, Messori A, Proli EM
ClinicoEconomics and Outcomes Research 2017, 9:525-535
Published Date: 29 August 2017
Technology that achieves the Triple Aim: an economic analysis of the BrainPathTM approach in neurosurgery
Norton SP, Dickerson EM, Kulwin CG, Shah MV
ClinicoEconomics and Outcomes Research 2017, 9:519-523
Published Date: 26 August 2017
A cost-effectiveness analysis of first-line induction and maintenance treatment sequences in patients with advanced nonsquamous non-small-cell lung cancer in France
Taipale K, Winfree KB, Boye M, Basson M, Sleilaty G, Eaton J, Evans R, Chouaid C
ClinicoEconomics and Outcomes Research 2017, 9:505-518
Published Date: 16 August 2017
Budget impact of somatostatin analogs as treatment for metastatic gastroenteropancreatic neuroendocrine tumors in US hospitals
Ortendahl JD, Pulgar SJ, Mirakhur B, Cox D, Bentley TGK, Phan AT
ClinicoEconomics and Outcomes Research 2017, 9:495-503
Published Date: 16 August 2017
Economic analysis and budget impact of clostridial collagenase ointment compared with medicinal honey for treatment of pressure ulcers in the US
Mearns ES, Liang M, Limone BL, Gilligan AM, Miller JD, Schaum KD, Waycaster CR
ClinicoEconomics and Outcomes Research 2017, 9:485-494
Published Date: 16 August 2017
A budget impact analysis of parenteral iron treatments for iron deficiency anemia in the UK: reduced resource utilization with iron isomaltoside 1000
Pollock RF, Muduma G
ClinicoEconomics and Outcomes Research 2017, 9:475-483
Published Date: 10 August 2017
The value of corneoscleral rim cultures in keratoplasty: a systematic review and cost-effectiveness analysis
Kiatos E, Armstrong JJ, Hutnik CML, Tsioros SM, Malvankar-Mehta MS, Hodge WG
ClinicoEconomics and Outcomes Research 2017, 9:459-474
Published Date: 9 August 2017
Clinical and economic analysis of outcomes of dose tapering or withdrawal of tumor necrosis factor-α inhibitors upon achieving stable disease activity in rheumatoid arthritis patients
Aletaha D, Snedecor SJ, Ektare V, Xue M, Bao Y, Garg V
ClinicoEconomics and Outcomes Research 2017, 9:451-458
Published Date: 28 July 2017
Cost analysis of adverse events associated with non-small cell lung cancer management in France
Chouaid C, Loirat D, Clay E, Millier A, Godard C, Fannan A, Lévy-Bachelot L, Angevin E
ClinicoEconomics and Outcomes Research 2017, 9:443-449
Published Date: 27 July 2017
Cost of illness of urothelial bladder cancer in Italy
Gerace C, Montorsi F, Tambaro R, Cartenì G, De Luca S, Tucci M, Martorana G, Basso U, Cardosi L, Teruzzi C
ClinicoEconomics and Outcomes Research 2017, 9:433-442
Published Date: 24 July 2017
Social and economic burden of patients with influenza-like illness and clinically diagnosed flu treated at various health facilities in Vietnam
Quang Vo T, Chaikledkaew U, Van Hoang M, Riewpaiboon A
ClinicoEconomics and Outcomes Research 2017, 9:423-432
Published Date: 19 July 2017
The cost utility and budget impact of adjuvant racecadotril for acute diarrhea in children in Thailand
Rautenberg TA, Zerwes U
ClinicoEconomics and Outcomes Research 2017, 9:411-422
Published Date: 17 July 2017
Mean cost per number needed to treat with tocilizumab plus methotrexate versus abatacept plus methotrexate in the treatment of rheumatoid arthritis in patients previously treated with methotrexate
Benucci M, Ravasio R, Damiani A
ClinicoEconomics and Outcomes Research 2017, 9:403-410
Published Date: 14 July 2017
Subgroup analysis of telehealthcare for patients with chronic obstructive pulmonary disease: the cluster-randomized Danish Telecare North Trial
Witt Udsen F, Lilholt PH, Hejlesen OK, Ehlers LH
ClinicoEconomics and Outcomes Research 2017, 9:391-401
Published Date: 7 July 2017
A cost analysis of a broad-spectrum antibiotic therapy in the empirical treatment of health care-associated infections in cirrhotic patients
Lucidi C, Di Gregorio V, Ceccarelli G, Venditti M, Riggio O, Merli M
ClinicoEconomics and Outcomes Research 2017, 9:385-390
Published Date: 29 June 2017
Burden of air leak complications in thoracic surgery estimated using a national hospital billing database
Yoo A, Ghosh SK, Danker W, Kassis E, Kalsekar I
ClinicoEconomics and Outcomes Research 2017, 9:373-383
Published Date: 29 June 2017
The economic and humanistic costs of chronic lower back pain in Japan
Montgomery W, Sato M, Nagasaka Y, Vietri J
ClinicoEconomics and Outcomes Research 2017, 9:361-371
Published Date: 23 June 2017
Community-based health insurance and communities' scheme requirement compliance in Thehuldere district, northeast Ethiopia: cross-sectional community-based study
Workneh SG, Biks GA, Woreta SA
ClinicoEconomics and Outcomes Research 2017, 9:353-359
Published Date: 14 June 2017
Economic and organizational sustainability of a negative-pressure portable device for the prevention of surgical-site complications
Foglia E, Ferrario L, Garagiola E, Signoriello G, Pellino G, Croce D, Canonico S
ClinicoEconomics and Outcomes Research 2017, 9:343-351
Published Date: 12 June 2017
Oncology drugs for orphan indications: how are HTA processes evolving for this specific drug category?
Adkins EM, Nicholson L, Floyd D, Ratcliffe M, Chevrou-Severac H
ClinicoEconomics and Outcomes Research 2017, 9:327-342
Published Date: 10 June 2017
Severe forms of fibromyalgia with acute exacerbation of pain: costs, comorbidities, and length of stay in inpatient care
Romeyke T, Noehammer E, Scheuer HC, Stummer H
ClinicoEconomics and Outcomes Research 2017, 9:317-325
Published Date: 1 June 2017
In-center hemodialysis absenteeism: prevalence and association with outcomes
Gray KS, Cohen DE, Brunelli SM
ClinicoEconomics and Outcomes Research 2017, 9:307-315
Published Date: 24 May 2017
Evaluation of the treatment patterns and economic burden of dysmenorrhea in Japanese women, using a claims database
Akiyama S, Tanaka E, Cristeau O, Onishi Y, Osuga Y
ClinicoEconomics and Outcomes Research 2017, 9:295-306
Published Date: 22 May 2017
Cost per care of the first year of direct antiviral agents in the Liguria Region: a multicenter analysis
Cenderello G, Fanizza C, Marenco S, Nicolini LA, Artioli S, Baldissarro I, Dentone C, De Leo P, Di Biagio A
ClinicoEconomics and Outcomes Research 2017, 9:281-293
Published Date: 22 May 2017
Medical resource utilization in dermatomyositis/polymyositis patients treated with repository corticotropin injection, intravenous immunoglobulin, and/or rituximab
Knight T, Bond TC, Popelar B, Wang L, Niewoehner JW, Anastassopoulos K, Philbin M
ClinicoEconomics and Outcomes Research 2017, 9:271-279
Published Date: 16 May 2017
A retrospective analysis of delays in the diagnosis of lung cancer and associated costs
Gildea TR, DaCosta Byfield S, Hogarth DK, Wilson DS, Quinn CC
ClinicoEconomics and Outcomes Research 2017, 9:261-269
Published Date: 12 May 2017
Adherence to disease-modifying therapies and its impact on relapse, health resource utilization, and costs among patients with multiple sclerosis
Burks J, Marshall TS, Ye X
ClinicoEconomics and Outcomes Research 2017, 9:251-260
Published Date: 28 April 2017
Gastroenterologist and nurse management of symptoms after pelvic radiotherapy for cancer: an economic evaluation of a clinical randomized controlled trial (the ORBIT study)
Jordan J, Gage H, Benton B, Lalji A, Norton C, Andreyev HJN
ClinicoEconomics and Outcomes Research 2017, 9:241-249
Published Date: 28 April 2017
Healthcare resource consumption and cost of care among patients with polycystic kidney disease in Italy
Degli Esposti L, Veronesi C, Perrone V, Buda S, Santoro A
ClinicoEconomics and Outcomes Research 2017, 9:233-239
Published Date: 27 April 2017
Budget impact analysis of the simplification to atazanavir + ritonavir + lamivudine dual therapy of HIV-positive patients receiving atazanavir-based triple therapies in Italy starting from data of the Atlas-M trial [Corrigendum]
Restelli U, Fabbiani M, Di Giambenedetto S, Nappi C, Croce D
ClinicoEconomics and Outcomes Research 2017, 9:231-232
Published Date: 19 April 2017
Cost-effectiveness analysis of abobotulinumtoxinA for the treatment of cervical dystonia in the United Kingdom
Muthukumar M, Desai K, Abogunrin S, Harrower T, Gabriel S, Dinet J
ClinicoEconomics and Outcomes Research 2017, 9:211-229
Published Date: 15 April 2017
Economic benefit of back titration in the treatment of hypertension in Jos, Nigeria
Okeahialam BN, Adeniyi MA
ClinicoEconomics and Outcomes Research 2017, 9:207-210
Published Date: 10 April 2017
Cost analysis of pulmonary lobectomy procedure: comparison of stapler versus precision dissection and sealant
Droghetti A, Marulli G, Vannucci J, Giovanardi M, Bottoli MC, Ragusa M, Muriana G
ClinicoEconomics and Outcomes Research 2017, 9:201-206
Published Date: 3 April 2017
Survey on attitudes of Italian pediatricians toward cough
Zanasi A, Morcaldi L, Cazzato S, Mazzolini M, Lecchi M, Morselli-Labate AM, Mastroroberto M, Dal Negro RW
ClinicoEconomics and Outcomes Research 2017, 9:189-199
Published Date: 16 March 2017
Topical medication utilization and health resources consumption in adult patients affected by psoriasis: findings from the analysis of administrative databases of local health units
Perrone V, Sangiorgi D, Buda S, Degli Esposti L
ClinicoEconomics and Outcomes Research 2017, 9:181-188
Published Date: 6 March 2017
Budget impact analysis of the simplification to atazanavir + ritonavir + lamivudine dual therapy of HIV-positive patients receiving atazanavir-based triple therapies in Italy starting from data of the Atlas-M trial
Restelli U, Fabbiani M, Di Giambenedetto S, Nappi C, Croce D
ClinicoEconomics and Outcomes Research 2017, 9:173-179
Published Date: 1 March 2017
Optimizing choice of oral interferon-free treatment for genotype 1 hepatitis C virus using testing for NS5A resistance: a cost-utility analysis from the perspective of the Italian National Health Service
Westerhout KY, Bouwmeester W, Duchesne I, Pisini M, Piena MA, Damele F, Gueron B, Treur M, Belsey J
ClinicoEconomics and Outcomes Research 2017, 9:163-172
Published Date: 27 February 2017
Home hemodialysis: a comprehensive review of patient-centered and economic considerations
Walker RC, Howard K, Morton RL
ClinicoEconomics and Outcomes Research 2017, 9:149-161
Published Date: 16 February 2017
Determinants of biological drug survival in rheumatoid arthritis: evidence from a Hungarian rheumatology center over 8 years of retrospective data
Brodszky V, Bíró A, Szekanecz Z, Soós B, Baji P, Rencz F, Tóthfalusi L, Gulácsi L, Péntek M
ClinicoEconomics and Outcomes Research 2017, 9:139-147
Published Date: 15 February 2017
Estimating the economic consequences of an increased medication adherence due to a potential improvement in the inhaler technique with Spiromax® compared with Turbuhaler® in patients with moderate-to-severe chronic obstructive pulmonary disease in Spain
Darbà J, Ramírez G, García-Rivero JL, Mayoralas S, Pascual JF, Vargas D, Bijedic A
ClinicoEconomics and Outcomes Research 2017, 9:127-137
Published Date: 10 February 2017
Time and resources of peripherally inserted central catheter insertion procedures: a comparison between blind insertion/chest X-ray and a real time tip navigation and confirmation system
Tomaszewski KJ, Ferko N, Hollmann SS, Eng SC, Richard HM, Rowe L, Sproule S
ClinicoEconomics and Outcomes Research 2017, 9:115-125
Published Date: 7 February 2017
Cost analysis of facial injury treatment in two university hospitals in Malaysia: a prospective study
Saperi BS, Ramli R, Ahmed Z, Muhd Nur A, Ibrahim MI, Rashdi MF, Nordin R, Rahman NA, Yusoff A, Nazimi AJ, Abdul Rahman R, Abdul Razak N, Mohamed N
ClinicoEconomics and Outcomes Research 2017, 9:107-113
Published Date: 7 February 2017
The cost-effectiveness of a NSCLC patient assistance program for pemetrexed maintenance therapy in People's Republic of China
Shi Q, Hu S, Furnback WE, Guzauskas GF, Shen J, Wang BCM
ClinicoEconomics and Outcomes Research 2017, 9:99-106
Published Date: 3 February 2017
Health care resource utilization before and after natalizumab initiation among patients with multiple sclerosis in Germany
Watson C, Prosser C, Braun S, Landsman-Blumberg PB, Gleissner E, Naoshy S
ClinicoEconomics and Outcomes Research 2017, 9:85-97
Published Date: 1 February 2017
Cost-effectiveness of SQ® HDM SLIT-tablet in addition to pharmacotherapy for the treatment of house dust mite allergic rhinitis in Germany
Green W, Kleine-Tebbe J, Klimek L, Hahn-Pedersen J, Nørgaard Andreasen J, Taylor M
ClinicoEconomics and Outcomes Research 2017, 9:77-84
Published Date: 16 February 2017
Potential resource and cost saving analysis of subcutaneous versus intravenous administration for rituximab in non-Hodgkin’s lymphoma and for trastuzumab in breast cancer in 17 Italian hospitals based on a systematic survey [Corrigendum]
Ponzetti C, Canciani M, Farina M, Era S, Walzer S
ClinicoEconomics and Outcomes Research 2017, 9:75-76
Published Date: 17 January 2017
Dalteparin versus vitamin K antagonists for the prevention of recurrent venous thromboembolism in patients with cancer and renal impairment: a Canadian pharmacoeconomic analysis
Dranitsaris G, Shane LG, Crowther M, Feugere G, Woodruff S
ClinicoEconomics and Outcomes Research 2017, 9:65-73
Published Date: 10 January 2017
Improving outpatient primary medication adherence with physician guided, automated dispensing
Moroshek JG
ClinicoEconomics and Outcomes Research 2017, 9:59-63
Published Date: 5 January 2017
Relative cost-effectiveness of using a liquid human milk fortifier in preterm infants in the US
Guest JF, Moya F, Sisk PM, Hudak ML, Kuehn D
ClinicoEconomics and Outcomes Research 2017, 9:49-57
Published Date: 4 January 2017
Cost-effectiveness analysis of combination antifungal therapy with voriconazole and anidulafungin versus voriconazole monotherapy for primary treatment of invasive aspergillosis in Spain
Grau S, Azanza JR, Ruiz I, Vallejo C, Mensa J, Maertens J, Heinz WJ, Barrueta JA, Peral C, Mesa FJ, Barrado M, Charbonneau C, Rubio-Rodríguez D, Rubio-Terrés C
ClinicoEconomics and Outcomes Research 2017, 9:39-47
Published Date: 30 December 2016
Costs of adverse events associated with erlotinib or afatinib in first-line treatment of advanced EGFR-positive non-small cell lung cancer
Isla D, De Castro J, Juan O, Grau S, Orofino J, Gordo R, Rubio-Terrés C, Rubio-Rodríguez D
ClinicoEconomics and Outcomes Research 2017, 9:31-38
Published Date: 30 December 2016
Real-world medication persistence and outcomes associated with basal insulin and glucagon-like peptide 1 receptor agonist free-dose combination therapy in patients with type 2 diabetes in the US
Lin J, Lingohr-Smith M, Fan T
ClinicoEconomics and Outcomes Research 2017, 9:19-29
Published Date: 22 December 2016
Persistence, switch rates, drug consumption and costs of biological treatment of rheumatoid arthritis: an observational study in Italy
Degli Esposti L, Favalli EG, Sangiorgi D, Di Turi R, Farina G, Gambera M, Ravasio R
ClinicoEconomics and Outcomes Research 2017, 9:9-17
Published Date: 21 December 2016
Economic report on the cost of dengue fever in Vietnam: case of a provincial hospital
Pham LD, Phung NHT, Le NTD, Vo TQ
ClinicoEconomics and Outcomes Research 2017, 9:1-8
Published Date: 16 December 2016
Treatment effectiveness and treatment patterns among rheumatoid arthritis patients after switching from a tumor necrosis factor inhibitor to another medication
Bonafede MMK, Curtis JR, McMorrow D, Mahajan P, Chen C
ClinicoEconomics and Outcomes Research 2016, 8:707-715
Published Date: 2 December 2016
Prioritizing health system and disease burden factors: an evaluation of the net benefit of transferring health technology interventions to different districts in Zimbabwe
Shamu S, Rusakaniko S, Hongoro C
ClinicoEconomics and Outcomes Research 2016, 8:695-705
Published Date: 24 November 2016
Patient-reported financial barriers to adherence to treatment in neurology
Moura LMVR, Schwamm EL, Moura Junior V, Seitz MP, Hoch DB, Hsu J, Schwamm LH
ClinicoEconomics and Outcomes Research 2016, 8:685-694
Published Date: 17 November 2016
Evaluating increased resource use in fibromyalgia using electronic health records
Margolis JM, Masters ET, Cappelleri JC, Smith DM, Faulkner S
ClinicoEconomics and Outcomes Research 2016, 8:675-683
Published Date: 16 November 2016
UK-specific cost-effectiveness of tiotropium + olodaterol fixed-dose combination versus other LAMA + LABA combinations in patients with COPD
Tebboth A, Ternouth A, Gonzalez-Rojas N
ClinicoEconomics and Outcomes Research 2016, 8:667-674
Published Date: 7 November 2016
Economic impact of longer battery life of cardiac resynchronization therapy defibrillators in Sweden
Gadler F, Ding Y, Verin N, Bergius M, Miller JD, Lenhart GM, Russell MW
ClinicoEconomics and Outcomes Research 2016, 8:657-666
Published Date: 31 October 2016
Residual cardiovascular risk in patients who received lipid-lowering treatment in a real-life setting: retrospective study
Perrone V, Sangiorgi D, Buda S, Degli Esposti L
ClinicoEconomics and Outcomes Research 2016, 8:649-655
Published Date: 25 October 2016
Health care resource use and costs associated with possible side effects of high oral corticosteroid use in asthma: a claims-based analysis
Luskin AT, Antonova EN, Broder MS, Chang EY, Omachi TA, Ledford DK
ClinicoEconomics and Outcomes Research 2016, 8:641-648
Published Date: 25 October 2016
Relative cost-effectiveness of using an extensively hydrolyzed casein formula in managing infants with cow’s milk allergy in Brazil
Guest JF, Yang AC, Oba J, Rodrigues M, Caetano R, Polster L
ClinicoEconomics and Outcomes Research 2016, 8:629-639
Published Date: 19 October 2016
The direct health-care burden of valvular heart disease: evidence from US national survey data
Moore M, Chen J, Mallow PJ, Rizzo JA
ClinicoEconomics and Outcomes Research 2016, 8:613-627
Published Date: 18 October 2016
Bringing patient centricity to diabetes medication access in Canada
Glennie JL, Kovacs Burns K, Oh P
ClinicoEconomics and Outcomes Research 2016, 8:599-611
Published Date: 17 October 2016
Disease progression and health care resource consumption in patients affected by hepatitis C virus in real practice setting
Perrone V, Sangiorgi D, Buda S, Degli Esposti L
ClinicoEconomics and Outcomes Research 2016, 8:591-597
Published Date: 14 October 2016
Cost-effectiveness of eplerenone in NYHA class II chronic heart failure patients with reduced LVEF: an analysis for Greece
Athanasakis K, Bilitou A, Lee D, Karampli E, Karavidas A, Parissis J, Sykara G, Kyriopoulos J
ClinicoEconomics and Outcomes Research 2016, 8:583-590
Published Date: 12 October 2016
Methods to construct a step-by-step beginner’s guide to decision analytic cost-effectiveness modeling
Rautenberg T, Hulme C, Edlin R
ClinicoEconomics and Outcomes Research 2016, 8:573-581
Published Date: 11 October 2016
Evaluating health-related quality of life in type 1 diabetes: a systematic literature review of utilities for adults with type 1 diabetes
Smith-Palmer J, Bae JP, Boye KS, Norrbacka K, Hunt B, Valentine WJ
ClinicoEconomics and Outcomes Research 2016, 8:559-571
Published Date: 7 October 2016
Health and economic benefits of physical activity for patients with spinal cord injury
Miller LE, Herbert WG
ClinicoEconomics and Outcomes Research 2016, 8:551-558
Published Date: 3 October 2016
Cost-effectiveness analysis of fesoterodine flexible dose in newly diagnosed patients with overactive bladder in routine clinical practice in Spain
Peral C, Sánchez-Ballester F, García-Mediero JM, Ramos J, Rejas J
ClinicoEconomics and Outcomes Research 2016, 8:541-550
Published Date: 26 September 2016
Cost-effectiveness analysis of online hemodiafiltration versus high-flux hemodialysis
Ramponi F, Ronco C, Mason G, Rettore E, Marcelli D, Martino F, Neri M, Martin-Malo A, Canaud B, Locatelli F
ClinicoEconomics and Outcomes Research 2016, 8:531-540
Published Date: 22 September 2016
Cost-effectiveness of dipeptidyl peptidase-4 inhibitor monotherapy in elderly type 2 diabetes patients in Thailand
Permsuwan U, Dilokthornsakul P, Saokaew S, Thavorn K, Chaiyakunapruk N
ClinicoEconomics and Outcomes Research 2016, 8:521-529
Published Date: 21 September 2016
A hospital cost analysis of a fibrin sealant patch in soft tissue and hepatic surgical bleeding
Corral M, Ferko N, Hogan A, Hollmann SS, Gangoli G, Jamous N, Batiller J, Kocharian R
ClinicoEconomics and Outcomes Research 2016, 8:507-519
Published Date: 21 September 2016
Patient-level costs of major cardiovascular conditions: a review of the international literature
Nicholson G, Gandra SR, Halbert RJ, Richhariya A, Nordyke RJ
ClinicoEconomics and Outcomes Research 2016, 8:495-506
Published Date: 21 September 2016
Economic evaluation of eribulin as second-line treatment for metastatic breast cancer in South Korea
Tremblay G, Majethia U, Breeze JL, Kontoudis I, Park J
ClinicoEconomics and Outcomes Research 2016, 8:485-493
Published Date: 19 September 2016
Economic evaluation of obinutuzumab in combination with chlorambucil in first-line treatment of patients with chronic lymphocytic leukemia in Spain
Casado LF, Burgos A, González-Haba E, Loscertales J, Krivasi T, Orofino J, Rubio-Terres C, Rubio-Rodríguez D
ClinicoEconomics and Outcomes Research 2016, 8:475-484
Published Date: 21 September 2016
Consequences of inaccurate hepatitis C virus genotyping on the costs of prescription of direct antiviral agents in an Italian district
Polilli E, Cento V, Restelli U, Ceccherini-Silberstein F, Aragri M, Di Maio VC, Sciacca A, Santoleri F, Fazii P, Costantini A, Perno CF, Parruti G
ClinicoEconomics and Outcomes Research 2016, 8:467-473
Published Date: 14 September 2016
Cost analysis of magnetically controlled growing rods compared with traditional growing rods for early-onset scoliosis in the US: an integrated health care delivery system perspective
Polly Jr DW, Ackerman SJ, Schneider K, Pawelek JB, Akbarnia BA
ClinicoEconomics and Outcomes Research 2016, 8:457-465
Published Date: 14 September 2016
Cost versus utility of aclidinium bromide 400 μg plus formoterol fumarate dihydrate 12 μg compared to aclidinium bromide 400 μg alone in the management of moderate-to-severe COPD
Ramos M, Haughney J, Henry N, Lindner L, Lamotte M
ClinicoEconomics and Outcomes Research 2016, 8:445-456
Published Date: 12 September 2016
A budget impact analysis of Spiromax® compared with Turbuhaler® for the treatment of moderate to severe asthma: a potential improvement in the inhalation technique to strengthen medication adherence could represent savings for the Spanish Healthcare System and five Spanish regions
Darbà J, Ramírez G, García-Rivero JL, Mayoralas-Alises S, Pascual JF, Roger A,Vargas D, Bijedic A
ClinicoEconomics and Outcomes Research 2016, 8:435-444
Published Date: 6 September 2016
Targeting improved patient outcomes using innovative product listing agreements: a survey of Canadian and international key opinion leaders
Thompson M, Henshall C, Garrison LP, Griffin AD, Coyle D, Long S, Khayat ZA, Anger DL, Yu R
ClinicoEconomics and Outcomes Research 2016, 8:427-433
Published Date: 26 August 2016
A systematic review of observational studies evaluating costs of adverse drug reactions
Batel Marques F, Penedones A, Mendes D, Alves C
ClinicoEconomics and Outcomes Research 2016, 8:413-426
Published Date: 24 August 2016
Impact of hospitalizations for bronchiolitis in preterm infants on long-term health care costs in Italy: a retrospective case-control study
Roggeri DP, Roggeri A, Rossi E, Cataudella S, Martini N
ClinicoEconomics and Outcomes Research 2016, 8:407-412
Published Date: 4 August 2016
Cost-effectiveness of primary debulking surgery when compared to neoadjuvant chemotherapy in the management of stage III C and IV epithelial ovarian cancer
Forde GK, Chang J, Ziogas A
ClinicoEconomics and Outcomes Research 2016, 8:397-406
Published Date: 2 August 2016
The epidemiology and burden of Alzheimer’s disease in Taiwan utilizing data from the National Health Insurance Research Database
Hung YN, Kadziola Z, Brnabic AJM, Yeh JF, Fuh JL, Hwang JP, Montgomery W
ClinicoEconomics and Outcomes Research 2016, 8:387-395
Published Date: 2 August 2016
Financial and feasibility implications of the treatment of hepatitis C virus in Italy: scenarios and perspectives
Croce D, Bonfanti M, Restelli U
ClinicoEconomics and Outcomes Research 2016, 8:377-385
Published Date: 8 August 2016
Work intensity in sacroiliac joint fusion and lumbar microdiscectomy
Frank C, Kondrashov D, Meyer SC, Dix G, Lorio M, Kovalsky D, Cher D
ClinicoEconomics and Outcomes Research 2016, 8:367-376
Published Date: 26 July 2016
Characterizing individual painDETECT symptoms by average pain severity
Sadosky A, Koduru V, Bienen EJ, Cappelleri JC
ClinicoEconomics and Outcomes Research 2016, 8:361-366
Published Date: 26 July 2016
Administrative risk quantification of subcutaneous and intravenous therapies in Italian centers utilizing the Failure Mode and Effects Analysis approach
Ponzetti C, Canciani M, Farina M, Era S, Walzer S
ClinicoEconomics and Outcomes Research 2016, 8:353-359
Published Date: 3 August 2016
Prolonged length of stay associated with air leak following pulmonary resection has a negative impact on hospital margin [Erratum]
Wood DE, Lauer LM, Layton A, Tong KB
ClinicoEconomics and Outcomes Research 2016, 8:351-352
Published Date: 15 July 2016
Ignoring the sacroiliac joint in chronic low back pain is costly [Corrigendum]
Polly DW, Cher D
ClinicoEconomics and Outcomes Research 2016, 8:349-350
Published Date: 8 July 2016
Screening strategies for active tuberculosis: focus on cost-effectiveness
Dobler CC
ClinicoEconomics and Outcomes Research 2016, 8:335-347
Published Date: 30 June 2016
Determination of the most appropriate method for extrapolating overall survival data from a placebo-controlled clinical trial of lenvatinib for progressive, radioiodine-refractory differentiated thyroid cancer
Tremblay G, Livings C, Crowe L, Kapetanakis V, Briggs A
ClinicoEconomics and Outcomes Research 2016, 8:323-333
Published Date: 30 June 2016
The use of sugammadex for bariatric surgery: analysis of recovery time from neuromuscular blockade and possible economic impact
De Robertis E, Zito Marinosci G, Romano GM, Piazza O, Iannuzzi M, Cirillo F, De Simone S, Servillo G
ClinicoEconomics and Outcomes Research 2016, 8:317-322
Published Date: 29 June 2016
Relative cost-effectiveness of using an extensively hydrolyzed casein formula containing the probiotic Lactobacillus rhamnosus GG in managing infants with cow's milk allergy in Poland
Guest JF, Weidlich D, Kaczmarski M, Jarocka-Cyrta E, Kobelska-Dubiel N, Krauze A, Sakowska-Maliszewska I, Zawadzka-Krajewska A
ClinicoEconomics and Outcomes Research 2016, 8:307-316
Published Date: 28 June 2016
Cost-effectiveness of minimally invasive sacroiliac joint fusion [Corrigendum]
Cher DJ, Frasco MA, Arnold RJG, Polly DW
ClinicoEconomics and Outcomes Research 2016, 8:305-306
Published Date: 27 June 2016
A structured review of health utility measures and elicitation in advanced/metastatic breast cancer
Hao Y, Wolfram V, Cook J
ClinicoEconomics and Outcomes Research 2016, 8:293-303
Published Date: 23 June 2016
Is the routine use of bevacizumab in the treatment of women with advanced or recurrent cancer of the cervix sustainable?
Klag N, Walter AC, Sheely KM, Manahan KJ, Geisler JP
ClinicoEconomics and Outcomes Research 2016, 8:287-291
Published Date: 21 June 2016
Economic analysis of empiric versus diagnostic-driven strategies for immunocompromised patients with suspected fungal infections in the People's Republic of China
Mao NY, Lesher B, Liu QF, Qin L, Chen YX, Gao X, Earnshaw SR, McDade CL, Charbonneau C
ClinicoEconomics and Outcomes Research 2016, 8:275-285
Published Date: 14 June 2016
A comparison of EuroQol 5-Dimension health-related utilities using Italian, UK, and US preference weights in a patient sample
Mozzi A, Meregaglia M, Lazzaro C, Tornatore V, Belfiglio M, Fattore G
ClinicoEconomics and Outcomes Research 2016, 8:267-274
Published Date: 13 June 2016
Scaling up health knowledge at European level requires sharing integrated data: an approach for collection of database specification
Menditto E, Bolufer de Gea A, Cahir C, Marengoni A, Riegler S, Fico G, Costa E, Monaco A, Pecorelli S, Pani L, Prados-Torres A
ClinicoEconomics and Outcomes Research 2016, 8:253-265
Published Date: 13 June 2016
Cost-effectiveness of tiotropium versus glycopyrronium in moderate to very severe chronic obstructive pulmonary disease in Canada, Spain, Sweden, and the UK
Eklund O, Afzal F, Borgström F, Flavin J, Ternouth A, Ojanguren ME, Crespo C, Baldwin M
ClinicoEconomics and Outcomes Research 2016, 8:243-252
Published Date: 11 June 2016
Savings associated with high-dose hypoallergenic house dust mite immunotherapy in rhinitis and/or asthma patients in Spain
García Robaina JC, Polanco Sánchez C, Estella Pérez E
ClinicoEconomics and Outcomes Research 2016, 8:235-241
Published Date: 14 June 2016
Potential resource and cost saving analysis of subcutaneous versus intravenous administration for rituximab in non-Hodgkin's lymphoma and for trastuzumab in breast cancer in 17 Italian hospitals based on a systematic survey
Ponzetti C, Canciani M, Farina M, Era S, Walzer S
ClinicoEconomics and Outcomes Research 2016, 8:227-233
Published Date: 23 May 2016
Cost-effectiveness of edoxaban versus rivaroxaban for stroke prevention in patients with nonvalvular atrial fibrillation (NVAF) in the US
Miller JD, Ye X, Lenhart GM, Farr AM, Tran OV, Kwong WJ, Magnuson EA, Weintraub WS
ClinicoEconomics and Outcomes Research 2016, 8:215-226
Published Date: 20 May 2016
The changing landscape of antiviral treatment of herpes zoster: a 17-year population-based cohort study
Friesen KJ, Alessi-Severini S, Chateau D, Falk J, Bugden S
ClinicoEconomics and Outcomes Research 2016, 8:207-214
Published Date: 20 May 2016
Estimated hospital costs associated with preventable health care-associated infections if health care antiseptic products were unavailable
Schmier JK, Hulme-Lowe CK, Semenova S, Klenk JA, DeLeo PC, Sedlak R, Carlson PA
ClinicoEconomics and Outcomes Research 2016, 8:197-205
Published Date: 13 May 2016
Prolonged length of stay associated with air leak following pulmonary resection has a negative impact on hospital margin
Wood DE, Lauer LM, Layton A, Tong KB
ClinicoEconomics and Outcomes Research 2016, 8:187-195
Published Date: 17 May 2016
Treatment patterns and health care resource utilization associated with dalfampridine extended release in multiple sclerosis: a retrospective claims database analysis
Guo A, Grabner M, Palli SR, Elder J, Sidovar M, Aupperle P, Krieger S
ClinicoEconomics and Outcomes Research 2016, 8:177-186
Published Date: 12 May 2016
The economic impact of educational training assessed by the Handling Questionnaire with three inhalation devices in asthma and Chronic Obstructive Pulmonary Disease patients
Dal Negro RW, Povero M
ClinicoEconomics and Outcomes Research 2016, 8:171-176
Published Date: 10 May 2016
Economic burden of refractory chronic spontaneous urticaria on Kuwait's health system
Al-Ahmad M, Alowayesh MS, Carroll NV
ClinicoEconomics and Outcomes Research 2016, 8:163-169
Published Date: 10 May 2016
Difficult-to-heal wounds of mixed arterial/venous and venous etiology: a cost-effectiveness analysis of extracellular matrix
Romanelli M, Gilligan AM, Waycaster CR, Dini V
ClinicoEconomics and Outcomes Research 2016, 8:153-161
Published Date: 4 May 2016
Cost-effectiveness of bortezomib for multiple myeloma: a systematic review
Chen W, Yang Y, Chen Y, Du F, Zhan H
ClinicoEconomics and Outcomes Research 2016, 8:137-151
Published Date: 3 May 2016
Hospitalization and cost after switching from atypical to typical antipsychotics in schizophrenia patients in Thailand
Boonlue T, Subongkot S, Dilokthornsakul P, Kongsakon R, Pattanaprateep O, Suanchang O, Chaiyakunapruk N
ClinicoEconomics and Outcomes Research 2016, 8:127-136
Published Date: 29 April 2016
A burden of illness study for neuropathic pain in Europe
Liedgens H, Obradovic M, De Courcy J, Holbrook T, Jakubanis R
ClinicoEconomics and Outcomes Research 2016, 8:113-126
Published Date: 27 April 2016
Real-world hospital costs for nonchemotherapy drugs and nondrug care associated with platinum-based doublets in the first-line setting for advanced nonsquamous non-small-cell lung cancer in Chinese patients: a retrospective cohort study
Chen JH, Wu S, Hu C, Yang Y, Rajan N, Chen Y, Yang C, Li J, Chen W
ClinicoEconomics and Outcomes Research 2016, 8:97-111
Published Date: 26 April 2016
Long-term outcomes in chronic obstructive pulmonary disease patients: exploring the effects of inhalatory devices and their influence on the outcome
Fadda V, Maratea D
ClinicoEconomics and Outcomes Research 2016, 8:87-95
Published Date: 15 April 2016
Productivity benefits of minimally invasive surgery in patients with chronic sacroiliac joint dysfunction
Saavoss JD, Koenig L, Cher DJ
ClinicoEconomics and Outcomes Research 2016, 8:77-85
Published Date: 11 April 2016
Designing economic evaluations to facilitate optimal decisions: the need to avoid bias
Lee KM, Coyle K, Coyle D
ClinicoEconomics and Outcomes Research 2016, 8:73-76
Published Date: 5 April 2016
Methicillin-resistant Staphylococcus aureus nosocomial pneumonia: role of linezolid in the People's Republic of China
Lesher B, Gao X, Chen Y, Liu Z
ClinicoEconomics and Outcomes Research 2016, 8:63-72
Published Date: 24 March 2016
Short- and longer-term health-care resource utilization and costs associated with acute ischemic stroke
Johnson BH, Bonafede MM, Watson C
ClinicoEconomics and Outcomes Research 2016, 8:53-61
Published Date: 23 February 2016
Sugammadex for reversal of neuromuscular blockade: a retrospective analysis of clinical outcomes and cost-effectiveness in a single center
Carron M, Baratto F, Zarantonello F, Ori C
ClinicoEconomics and Outcomes Research 2016, 8:43-52
Published Date: 18 February 2016
Costs associated with rheumatoid arthritis in Italy: past, present, and future
Benucci M, Rogai V, Atzeni F, Hammen V, Sarzi-Puttini P, Migliore A
ClinicoEconomics and Outcomes Research 2016, 8:33-41
Published Date: 10 February 2016
Ignoring the sacroiliac joint in chronic low back pain is costly
Polly DW, Cher D
ClinicoEconomics and Outcomes Research 2016, 8:23-31
Published Date: 21 January 2016
Budget impact analysis of sofosbuvir-based regimens for the treatment of HIV/HCV-coinfected patients in northern Italy: a multicenter regional simulation
Cenderello G, Artioli S, Viscoli C, Pasa A, Giacomini M, Giannini B, Dentone C, Nicolini LA, Cassola G, Di Biagio A
ClinicoEconomics and Outcomes Research 2016, 8:15-21
Published Date: 31 December 2015
Cost-effectiveness of minimally invasive sacroiliac joint fusion
Cher DJ, Frasco MA, Arnold RJG, Polly DW
ClinicoEconomics and Outcomes Research 2016, 8:1-14
Published Date: 18 December 2015
The impact of ribavirin on real-world adherence rates in hepatitis C patients treated with sofosbuvir plus simeprevir
Walker DR, Juday TR, Manthena SR, Jing Y, Sood V
ClinicoEconomics and Outcomes Research 2015, 7:637-642
Published Date: 17 December 2015
Adjustment of foreign EQ-5D-3L utilities can increase their transferability
Oddershede L, Petersen KD
ClinicoEconomics and Outcomes Research 2015, 7:629-636
Published Date: 15 December 2015
Estimating health-state utility values for patients with recurrent ovarian cancer using Functional Assessment of Cancer Therapy – General mapping algorithms
Hettle R, Borrill J, Suri G, Wulff J
ClinicoEconomics and Outcomes Research 2015, 7:615-627
Published Date: 26 November 2015
Gastrointestinal events and association with initiation of treatment for osteoporosis
Modi A, Siris ES, Tang J, Sajjan S, Sen SS
ClinicoEconomics and Outcomes Research 2015, 7:603-613
Published Date: 25 November 2015
Productivity loss and resource utilization, and associated indirect and direct costs in individuals providing care for adults with schizophrenia in the EU5
Gupta S, Isherwood G, Jones K, Van Impe K
ClinicoEconomics and Outcomes Research 2015, 7:593-602
Published Date: 25 November 2015
Relative cost-effectiveness of using an extensively hydrolyzed casein formula containing the probiotic Lactobacillus rhamnosus GG in managing infants with cow’s milk allergy in Spain
Guest JF, Weidlich D, Mascuñán Díaz JI, Díaz JJ, Ojeda PM, Ferrer-González JP, Gil D, Onrubia I, Rincón Víctor P
ClinicoEconomics and Outcomes Research 2015, 7:583-591
Published Date: 23 November 2015
Doctors commitment and long-term effectiveness for cost containment policies: lesson learned from biosimilar drugs
Menditto E, Orlando V, Coretti S, Putignano D, Fiorentino D, Ruggeri M
ClinicoEconomics and Outcomes Research 2015, 7:575-581
Published Date: 11 November 2015
Variation in hospital resource use and cost among surgical procedures using topical absorbable hemostats
Martyn D, Meckley LM, Miyasato G, Lim S, Riebman JB, Kocharian R, Scaife JG, Rao Y, Corral M
ClinicoEconomics and Outcomes Research 2015, 7:567-574
Published Date: 6 November 2015
Impact of treatment with rosuvastatin and atorvastatin on cardiovascular outcomes: evidence from the Archimedes-simulated clinical trials
Colivicchi F, Sternhufvud C, Gandhi SK
ClinicoEconomics and Outcomes Research 2015, 7:555-565
Published Date: 27 November 2015
The financial burden of sickle cell disease on households in Ekiti, Southwest Nigeria
Olatunya OS, Ogundare EO, Fadare JO, Oluwayemi IO, Agaja OT, Adeyefa BS, Aderiye O
ClinicoEconomics and Outcomes Research 2015, 7:545-553
Published Date: 4 November 2015
The expenditures related to the use of antifungal drugs in patients with hematological cancers: a cost analysis
Gedik H
ClinicoEconomics and Outcomes Research 2015, 7:537-543
Published Date: 3 November 2015
Cost-effectiveness of three echinocandins and fluconazole in the treatment of candidemia and/or invasive candidiasis in nonneutropenic adult patients
Grau S, Pozo JC, Romá E, Salavert M, Barrueta JA, Peral C, Rodriguez I, Rubio-Rodríguez D, Rubio-Terrés C
ClinicoEconomics and Outcomes Research 2015, 7:527-535
Published Date: 13 October 2015
Linezolid for the treatment of hospital-acquired pneumonia in a Chinese tertiary hospital
Lesher BA, Liu Z, Chen Y, Gao X
ClinicoEconomics and Outcomes Research 2015, 7:521-526
Published Date: 9 October 2015
Cost-effectiveness analysis of pregabalin for treatment of chronic low back pain in patients with accompanying lower limb pain (neuropathic component) in Japan
Igarashi A, Akazawa M, Murata T, Taguchi T, Sadosky A, Ebata N, Willke R, Fujii K, Doherty J, Kobayashi M
ClinicoEconomics and Outcomes Research 2015, 7:505-520
Published Date: 7 October 2015
Bias within economic evaluations – the impact of considering the future entry of lower-cost generics on currently estimated incremental cost-effectiveness ratios of a new drug
Guertin JR, Mitchell D, Ali F, LeLorier J
ClinicoEconomics and Outcomes Research 2015, 7:497-503
Published Date: 6 October 2015
Annual impact of scribes on physician productivity and revenue in a cardiology clinic
Bank AJ, Gage RM
ClinicoEconomics and Outcomes Research 2015, 7:489-495
Published Date: 30 September 2015
Estimating the health care burden of prescription opioid abuse in five European countries
Shei A, Hirst M, Kirson NY, Enloe CJ, Birnbaum HG, Dunlop WCN
ClinicoEconomics and Outcomes Research 2015, 7:477-488
Published Date: 15 September 2015
Acceptance of health technology assessment submissions with incremental cost-effectiveness ratios above the cost-effectiveness threshold
Griffiths EA, Hendrich JK, Stoddart SDR, Walsh SCM
ClinicoEconomics and Outcomes Research 2015, 7:463-476
Published Date: 31 August 2015
Review of the cost of venous thromboembolism
Fernandez MM, Hogue S, Preblick R, Kwong WJ
ClinicoEconomics and Outcomes Research 2015, 7:451-462
Published Date: 28 August 2015
AbobotulinumtoxinA in the management of cervical dystonia in the United Kingdom: a budget impact analysis
Abogunrin S, Brand S, Desai K, Dinet J, Gabriel S, Harrower T
ClinicoEconomics and Outcomes Research 2015, 7:441-449
Published Date: 9 September 2015
A narrative review of cost-effectiveness analysis of people living with HIV treated with HAART: from interventions to outcomes
Tse WF, Yang W, Huang W
ClinicoEconomics and Outcomes Research 2015, 7:431-439
Published Date: 11 August 2015
Medical resource utilization for administration of trastuzumab in a New Zealand oncology outpatient setting: a time and motion study
North RT, Harvey VJ, Cox LC, Ryan SN
ClinicoEconomics and Outcomes Research 2015, 7:423-430
Published Date: 29 July 2015
Health and economic outcomes associated with uncontrolled surgical bleeding: a retrospective analysis of the Premier Perspectives Database
Corral M, Ferko N, Hollmann S, Broder MS, Chang E
ClinicoEconomics and Outcomes Research 2015, 7:409-421
Published Date: 22 July 2015
Retrospective analysis of drug utilization, health care resource use, and costs associated with IFN therapy for adjuvant treatment of malignant melanoma
Zhang Y, Le TK, Shaw JW, Kotapati S
ClinicoEconomics and Outcomes Research 2015, 7:397-407
Published Date: 21 July 2015
Relationship between patient dependence and direct medical-, social-, indirect-, and informal-care costs in Spain
Darbà J, Kaskens L
ClinicoEconomics and Outcomes Research 2015, 7:387-395
Published Date: 2 July 2015
Impact of noncommunicable diseases in the State of Qatar
Al-Kaabi SK, Atherton A
ClinicoEconomics and Outcomes Research 2015, 7:377-385
Published Date: 2 July 2015
Cost and effectiveness of omega-3 fatty acid supplementation in Chinese ICU patients receiving parenteral nutrition
Wu GH, Gao J, Ji CY, Pradelli L, Xi QL, Zhuang QL
ClinicoEconomics and Outcomes Research 2015, 7:369-375
Published Date: 26 June 2015
Association of persistent and transient worsening renal function with mortality risk, readmissions risk, length of stay, and costs in patients hospitalized with acute heart failure
Palmer JB, Friedman HS, Waltman Johnson K, Navaratnam P, Gottlieb SS
ClinicoEconomics and Outcomes Research 2015, 7:357-367
Published Date: 19 June 2015
Economic value of in vitro fertilization in Ukraine, Belarus, and Kazakhstan
Mandrik O, Knies S, Severens JL
ClinicoEconomics and Outcomes Research 2015, 7:347-356
Published Date: 12 June 2015
Medical costs associated with cardiovascular events among high-risk patients with hyperlipidemia
Bonafede MM, Johnson BH, Richhariya A, Gandra SR
ClinicoEconomics and Outcomes Research 2015, 7:337-345
Published Date: 9 June 2015
Relative cost-effectiveness of an extensively hydrolyzed casein formula containing the probiotic Lactobacillus rhamnosus GG in managing infants with cow's milk allergy in Italy
Guest JF, Panca M, Ovcinnikova O, Nocerino R
ClinicoEconomics and Outcomes Research 2015, 7:325-336
Published Date: 8 June 2015
Clinical trial simulation methods for estimating the impact of DPP-4 inhibitors on cardiovascular disease
Schuetz CA, Ong SH, Blüher M
ClinicoEconomics and Outcomes Research 2015, 7:313-323
Published Date: 5 June 2015
Comparative effectiveness and costs of generic and brand-name gabapentin and venlafaxine in patients with neuropathic pain or generalized anxiety disorder in Spain
Sicras-Mainar A, Rejas-Gutiérrez J, Navarro-Artieda R
ClinicoEconomics and Outcomes Research 2015, 7:299-312
Published Date: 4 June 2015
Evolution of health technology assessment: best practices of the pan-Canadian Oncology Drug Review
Rocchi A, Chabot I, Glennie J
ClinicoEconomics and Outcomes Research 2015, 7:287-298
Published Date: 3 June 2015
Prevalence and cost of imaging in inpatient falls: the rising cost of falling
Fields J, Alturkistani T, Kumar N, Kanuri A, Salem DN, Munn S, Blazey-Martin D
ClinicoEconomics and Outcomes Research 2015, 7:281-286
Published Date: 3 June 2015
Adherence to statin treatment following a myocardial infarction: an Italian population-based survey
Monaldi B, Bologna G, Costa GG, D'Agostino C, Ferrante F, Filice M, Grion A, Mingarelli A, Paloscia L, Tettamanti R, Veronesi C, Degli Esposti L
ClinicoEconomics and Outcomes Research 2015, 7:273-280
Published Date: 1 June 2015
Modeling the budget impact of long-acting injectable paliperidone palmitate in the treatment of schizophrenia in Japan
Mahlich J, Nishi M, Saito Y
ClinicoEconomics and Outcomes Research 2015, 7:267-272
Published Date: 22 May 2015
Application of a validated algorithm to estimate the effectiveness and cost of biologics for rheumatoid arthritis in the US pharmacy benefit manager context
Wu N, Bhurke S, Shah N, Harrison DJ
ClinicoEconomics and Outcomes Research 2015, 7:257-266
Published Date: 13 May 2015
Nab-paclitaxel, docetaxel, or solvent-based paclitaxel in metastatic breast cancer: a cost-utility analysis from a Chinese health care perspective
Dranitsaris G, Yu B, King J, Kaura S, Zhang A
ClinicoEconomics and Outcomes Research 2015, 7:249-256
Published Date: 12 May 2015
Cost-effectiveness of ranibizumab versus aflibercept in the treatment of visual impairment due to diabetic macular edema: a UK healthcare perspective
Régnier SA, Malcolm W, Haig J, Xue W
ClinicoEconomics and Outcomes Research 2015, 7:235-247
Published Date: 6 May 2015
A potential gender bias in assessing quality of life – a standard gamble experiment among university students
Al Obaidi L, Mahlich J
ClinicoEconomics and Outcomes Research 2015, 7:227-233
Published Date: 24 April 2015
Incorporating ulipristal acetate in the care of symptomatic uterine fibroids: a Canadian cost-utility analysis of pharmacotherapy management
Tsoi B, Blackhouse G, Ferrazzi S, Reade CJ, Chen I, Goeree R
ClinicoEconomics and Outcomes Research 2015, 7:213-225
Published Date: 17 April 2015
Inpatient cost of treating osteoporotic fractures in mainland China: a descriptive analysis
Yang YC, Du F, Ye WY, Chen Y, Li JH, Zhang J, Nicely H, Burge R
ClinicoEconomics and Outcomes Research 2015, 7:205-212
Published Date: 13 April 2015
Health economic evaluations of medical devices in the People's Republic of China: A systematic literature review
Zhang R, Modaresi F, Borisenko O
ClinicoEconomics and Outcomes Research 2015, 7:195-204
Published Date: 9 April 2015
Budget impact analysis of botulinum toxin A therapy for upper limb spasticity in the United Kingdom
Abogunrin S, Hortobagyi L, Remak E, Dinet J, Gabriel S, Bakheit AM
ClinicoEconomics and Outcomes Research 2015, 7:185-193
Published Date: 1 April 2015
The impact of chronic pain on direct medical utilization and costs in chronic obstructive pulmonary disease
Roberts MH, Mapel DW, Thomson HN
ClinicoEconomics and Outcomes Research 2015, 7:173-184
Published Date: 26 March 2015
Disability-adjusted life years lost due to diabetes in France, Italy, Germany, Spain, and the United Kingdom: a burden of illness study
Darbà J, Kaskens L, Detournay B, Kern W, Nicolucci A, Orozco-Beltrán D, Ramírez de Arellano A
ClinicoEconomics and Outcomes Research 2015, 7:163-171
Published Date: 23 March 2015
Annual biologic treatment cost for new and existing patients with moderate to severe plaque psoriasis in Greece [Corrigendum]
Fragoulakis V, Raptis E, Vitsou E, Maniadakis N
ClinicoEconomics and Outcomes Research 2015, 7:161-162
Published Date: 17 March 2015
Costs of illness analysis in Italian patients with chronic obstructive pulmonary disease (COPD): an update
Dal Negro RW, Bonadiman L, Turco P, Tognella S, Iannazzo S
ClinicoEconomics and Outcomes Research 2015, 7:153-159
Published Date: 16 March 2015
Cost-effectiveness of using an extensively hydrolyzed casein formula plus the probiotic Lactobacillus rhamnosus GG compared to an extensively hydrolyzed formula alone or an amino acid formula as first-line dietary management for cow’s milk allergy in the US
Ovcinnikova O, Panca M, Guest JF
ClinicoEconomics and Outcomes Research 2015, 7:145-152
Published Date: 27 February 2015
Health services financing and delivery: analysis of policy options for Dubai, United Arab Emirates
Hamidi S
ClinicoEconomics and Outcomes Research 2015, 7:133-143
Published Date: 25 February 2015
Medical resource utilization and costs associated with autosomal dominant polycystic kidney disease in the USA: a retrospective matched cohort analysis of private insurer data
Knight T, Schaefer C, Krasa H, Oberdhan D, Chapman A, Perrone RD
ClinicoEconomics and Outcomes Research 2015, 7:123-132
Published Date: 20 February 2015
Health economics, equity, and efficiency: are we almost there?
Ferraz MB
ClinicoEconomics and Outcomes Research 2015, 7:119-122
Published Date: 12 February 2015
Cost-utility of denosumab for the treatment of postmenopausal osteoporosis in Spain
Darbà J, Kaskens L, Sorio Vilela F, Lothgren M
ClinicoEconomics and Outcomes Research 2015, 7:105-117
Published Date: 9 February 2015
Estimating the real world daily usage and cost for exenatide twice daily and liraglutide in Germany, the Netherlands, and the UK based on volumes dispensed by pharmacies
McDonell AL, Kiiskinen U, Zammit DC, Kotchie RW, Thuresson PO, Nicolay C, Haslam T, Bruinsma M, Janszen-Van Oosterhout AJ, Otto T
ClinicoEconomics and Outcomes Research 2015, 7:95-103
Published Date: 30 January 2015
Economic evaluation of anti-TNF agents for patients with rheumatoid arthritis in Greece
Fragoulakis V, Vitsou E, Hernandez AC, Maniadakis N
ClinicoEconomics and Outcomes Research 2015, 7:85-93
Published Date: 16 January 2015
Annual biologic treatment cost for new and existing patients with moderate to severe plaque psoriasis in Greece
Fragoulakis V, Raptis E, Vitsou E, Maniadakis N
ClinicoEconomics and Outcomes Research 2015, 7:73-83
Published Date: 8 January 2015
End-stage renal disease in autosomal dominant polycystic kidney disease: a comparison of dialysis-related utilization and costs with other chronic kidney diseases
Brunelli SM, Blanchette CM, Claxton AJ, Roy D, Rossetti S, Gutierrez B
ClinicoEconomics and Outcomes Research 2015, 7:65-72
Published Date: 6 January 2015
Value analysis of digital breast tomosynthesis for breast cancer screening in a commercially-insured US population
Bonafede MM, Kalra VB, Miller JD, Fajardo LL
ClinicoEconomics and Outcomes Research 2015, 7:53-63
Published Date: 12 January 2015
Assessing the importance of predictors in unplanned hospital readmissions for chronic obstructive pulmonary disease
Yu TC, Zhou H, Suh K, Arcona S
ClinicoEconomics and Outcomes Research 2015, 7:37-51
Published Date: 6 January 2015
Cost of HAART in Italy: multicentric evaluation and determinants from a large HIV outpatient cohort
Tontodonati M, Cenderello G, Celesia BM, Trezzi M, Ursini T, Costantini A, Marra D, Polilli E, Catalani C, Butini L, Sozio F, Mazzotta E, Sciacca A, Rizzardini G, Manzoli L, Cozzi-Lepri A, Parruti G
ClinicoEconomics and Outcomes Research 2015, 7:27-35
Published Date: 22 December 2014
Cost–consequence analysis of long-term prophylaxis in the treatment of von Willebrand disease in the Italian context
Schinco P, Cultrera D, Valeri F, Borchiellini A, Mantuano M, Gorla F, Savarese A, Teruzzi C
ClinicoEconomics and Outcomes Research 2015, 7:17-25
Published Date: 17 December 2014
Economic evaluation of first-line and maintenance treatments for advanced non-small cell lung cancer: a systematic review
Chouaïd C, Crequit P, Borget I, Vergnenegre A
ClinicoEconomics and Outcomes Research 2015, 7:9-15
Published Date: 15 December 2014
The costs of fluid overload in the adult intensive care unit: is a small-volume infusion model a proactive solution?
Child DL, Cao Z, Seiberlich LE, Brown H, Greenberg J, Swanson A, Sewall MR, Robinson SB
ClinicoEconomics and Outcomes Research 2015, 7:1-8
Published Date: 15 December 2014
Effect of occasional epoetin use in combination with a stable darbepoetin dosage on anemia management in hemodialysis patients
Shimamatsu K
ClinicoEconomics and Outcomes Research 2014, 6:531-535
Published Date: 9 December 2014
Different strategies and cost-effectiveness in the treatment of primary open angle glaucoma
Ting NSJ, Li Yim JFT, Ng JY
ClinicoEconomics and Outcomes Research 2014, 6:523-530
Published Date: 4 December 2014
Level, pattern, and determinants of polypharmacy and inappropriate use of medications by village doctors in a rural area of Bangladesh
Rasu RS, Iqbal M, Hanifi SMA, Moula A, Hoque S, Rasheed S, Bhuiya A
ClinicoEconomics and Outcomes Research 2014, 6:515-521
Published Date: 3 December 2014
Seriousness, preventability, and burden impact of reported adverse drug reactions in Lombardy emergency departments: a retrospective 2-year characterization
Perrone V, Conti V, Venegoni M, Scotto S, Degli Esposti L, Sangiorgi D, Prestini L, Radice S, Clementi E, Vighi G
ClinicoEconomics and Outcomes Research 2014, 6:505-514
Published Date: 3 December 2014
Measurement properties of painDETECT by average pain severity
Cappelleri JC, Bienen EJ, Koduru V, Sadosky A
ClinicoEconomics and Outcomes Research 2014, 6:497-504
Published Date: 6 November 2014
Pain severity and the economic burden of neuropathic pain in the United States: BEAT Neuropathic Pain Observational Study
Schaefer C, Sadosky A, Mann R, Daniel S, Parsons B, Tuchman M, Anschel A, Stacey BR, Nalamachu S, Nieshoff E
ClinicoEconomics and Outcomes Research 2014, 6:483-496
Published Date: 29 October 2014
Exploring the willingness to pay for a quality-adjusted life-year in the state of Penang, Malaysia
Shafie AA, Lim YW, Chua GN, Hassali MA
ClinicoEconomics and Outcomes Research 2014, 6:473-481
Published Date: 23 October 2014
Clinical outcomes and health care costs combining metformin with sitagliptin or sulphonylureas or thiazolidinediones in uncontrolled type 2 diabetes patients
Degli Esposti L, Saragoni S, Buda S, Degli Esposti E
ClinicoEconomics and Outcomes Research 2014, 6:463-472
Published Date: 21 October 2014
Clinical response and hospital costs associated with the empirical use of vancomycin and linezolid for hospital-acquired pneumonia in a Chinese tertiary care hospital: a retrospective cohort study
Song Y, Yang Y, Chen W, Liu W, Wang K, Li X, Wang K, Papadimitropoulos M, Montgomery W
ClinicoEconomics and Outcomes Research 2014, 6:451-461
Published Date: 17 October 2014
Economic burden of asthma in Abu Dhabi: a retrospective study
Alzaabi A, Alseiari M, Mahboub B
ClinicoEconomics and Outcomes Research 2014, 6:445-450
Published Date: 17 October 2014
A medicoeconomic review of early intervention with biologic agents in the treatment of inflammatory bowel diseases
Odes S, Greenberg D
ClinicoEconomics and Outcomes Research 2014, 6:431-443
Published Date: 8 October 2014
Retrospective database analysis of clinical outcomes and costs for treatment of abnormal uterine bleeding among women enrolled in US Medicaid programs
Bonafede MM, Miller JD, Laughlin-Tommaso SK, Lukes AS, Meyer NM, Lenhart GM
ClinicoEconomics and Outcomes Research 2014, 6:423-429
Published Date: 8 October 2014
Laparoscopic versus open colorectal resection for cancer and polyps: a cost-effectiveness study
Jordan J, Dowson H, Gage H, Jackson D, Rockall T
ClinicoEconomics and Outcomes Research 2014, 6:415-422
Published Date: 26 September 2014
Budget impact analysis of antiretroviral less drug regimen simplification in HIV-positive patients on the Italian National Health Service
Restelli U, Andreoni M, Antinori A, Bonfanti M, Di Perri G, Galli M, Lazzarin A, Rizzardini G, Croce D
ClinicoEconomics and Outcomes Research 2014, 6:409-414
Published Date: 23 September 2014
Adherence and resource use among patients treated with biologic drugs: findings from BEETLE study
Degli Esposti L, Sangiorgi D, Perrone V, Radice S, Clementi E, Perone F, Buda S
ClinicoEconomics and Outcomes Research 2014, 6:401-407
Published Date: 18 September 2014
Impact of potential pregabalin or duloxetine drug–drug interactions on health care costs and utilization among Medicare members with fibromyalgia
Ellis JJ, Sadosky AB, Ten Eyck LL, Cappelleri JC, Brown CR, Suehs BT, Parsons B
ClinicoEconomics and Outcomes Research 2014, 6:389-399
Published Date: 14 October 2014
Cost of tumor necrosis factor blockers per patient with rheumatoid arthritis in a multistate Medicaid population
Bonafede M, Joseph GJ, Shah N, Princic N, Harrison DJ
ClinicoEconomics and Outcomes Research 2014, 6:381-388
Published Date: 15 September 2014
Economic burden associated with chronic constipation in Sweden: a retrospective cohort study
Bruce Wirta S, Hodgkins P, Joseph A
ClinicoEconomics and Outcomes Research 2014, 6:369-379
Published Date: 12 August 2014
Oncology drug health technology assessment recommendations: Canadian versus UK experiences
Chabot I, Rocchi A
ClinicoEconomics and Outcomes Research 2014, 6:357-367
Published Date: 16 July 2014
Costs and health care resource utilization among chronic obstructive pulmonary disease patients with newly acquired pneumonia
Lin J, Li Y, Tian H, Goodman MJ, Gabriel S, Nazareth T, Turner SJ, Arcona S, Kahler KH
ClinicoEconomics and Outcomes Research 2014, 6:349-356
Published Date: 16 July 2014
Impact of therapeutic drug monitoring of antiretroviral drugs in routine clinical management of patients infected with human immunodeficiency virus and related health care costs: a real-life study in a large cohort of patients
Perrone V, Cattaneo D, Radice S, Sangiorgi D, Federici AB, Gismondo MR, Medaglia M, Micheli V, Vimercati S, Pallone E, Degli Esposti L, Clementi E
ClinicoEconomics and Outcomes Research 2014, 6:341-348
Published Date: 14 July 2014
Considerations for payers in managing hormone receptor-positive advanced breast cancer
Chitre M, Reimers KM
ClinicoEconomics and Outcomes Research 2014, 6:331-339
Published Date: 10 July 2014
Cost-effectiveness of continuous erythropoietin receptor activator in anemia
Schmid H
ClinicoEconomics and Outcomes Research 2014, 6:319-330
Published Date: 3 July 2014
Cost of opioid intravenous patient-controlled analgesia: results from a hospital database analysis and literature assessment
Palmer P, Ji X, Stephens J
ClinicoEconomics and Outcomes Research 2014, 6:311-318
Published Date: 20 June 2014
Health policy model: long-term predictive results associated with the management of hepatitis C virus-induced diseases in Italy
Mennini FS, Marcellusi A, Andreoni M, Gasbarrini A, Salomone S, Craxì A
ClinicoEconomics and Outcomes Research 2014, 6:303-310
Published Date: 19 June 2014
Economic impact of infections among patients with primary immunodeficiency disease receiving IVIG therapy
Menzin J, Sussman M, Munsell M, Zbrozek A
ClinicoEconomics and Outcomes Research 2014, 6:297-302
Published Date: 10 June 2014
Comparison of the costs of nonoperative care to minimally invasive surgery for sacroiliac joint disruption and degenerative sacroiliitis in a United States commercial payer population: potential economic implications of a new minimally invasive technology
Ackerman SJ, Polly Jr DW, Knight T, Schneider K, Holt T, Cummings Jr J
ClinicoEconomics and Outcomes Research 2014, 6:283-296
Published Date: 24 May 2014
Opioid-induced constipation in patients with chronic noncancer pain in the USA, Canada, Germany, and the UK: descriptive analysis of baseline patient-reported outcomes and retrospective chart review
Coyne KS, LoCasale RJ, Datto CJ, Sexton CC, Yeomans K, Tack J
ClinicoEconomics and Outcomes Research 2014, 6:269-281
Published Date: 23 May 2014
Conversion of the Seattle Angina Questionnaire into EQ-5D utilities for ischemic heart disease: a systematic review and catalog of the literature
Wijeysundera HC, Farshchi-Zarabi S, Witteman W, Bennell MC
ClinicoEconomics and Outcomes Research 2014, 6:253-268
Published Date: 19 May 2014
Health economics evidence for medical nutrition: are these interventions value for money in integrated care?
Walzer S, Droeschel D, Nuijten M, Chevrou-Séverac H
ClinicoEconomics and Outcomes Research 2014, 6:241-252
Published Date: 19 May 2014
Dressing-related trauma: clinical sequelae and resource utilization in a UK setting
Charlesworth B, Pilling C, Chadwick P, Butcher M
ClinicoEconomics and Outcomes Research 2014, 6:227-239
Published Date: 28 April 2014
Respiratory syncytial virus: current and emerging treatment options
Turner TL, Kopp BT, Paul G, Landgrave LC, Hayes D Jr, Thompson R
ClinicoEconomics and Outcomes Research 2014, 6:217-225
Published Date: 25 April 2014
Drug adherence to olmesartan/amlodipine fixed combination in an Italian clinical practice setting
Degli Esposti L, Saragoni S, Buda S, Degli Esposti E
ClinicoEconomics and Outcomes Research 2014, 6:209-216
Published Date: 22 April 2014
Group-based trajectory modeling to assess adherence to biologics among patients with psoriasis
Li Y, Zhou H, Cai B, Kahler KH, Tian H, Gabriel S, Arcona S
ClinicoEconomics and Outcomes Research 2014, 6:197-208
Published Date: 10 April 2014
Economic evaluation of SQ-standardized grass allergy immunotherapy tablet (Grazax®) in children
Ronaldson S, Taylor M, Bech PG, Shenton R, Bufe A
ClinicoEconomics and Outcomes Research 2014, 6:187-196
Published Date: 8 April 2014
Economic evaluation of aclidinium bromide in the management of moderate to severe COPD: an analysis over 5 years
Karabis A, Mocarski M, Eijgelshoven I, Bergman G
ClinicoEconomics and Outcomes Research 2014, 6:175-185
Published Date: 5 April 2014
Economic burden of torture for a refugee host country: development of a model and presentation of a country case study
Mpinga EK, Frey C, Chastonay P
ClinicoEconomics and Outcomes Research 2014, 6:165-173
Published Date: 2 April 2014
Economic and humanistic burden of illness in generalized anxiety disorder: an analysis of patient survey data in Europe
Toghanian S, DiBonaventura M, Järbrink K, Locklear JC
ClinicoEconomics and Outcomes Research 2014, 6:151-163
Published Date: 2 April 2014
Economic implications of using bendamustine, alemtuzumab, or chlorambucil as a first-line therapy for chronic lymphocytic leukemia in the US: a cost-effectiveness analysis
Kongnakorn T, Sterchele JA, Salvador CG, Getsios D, Mwamburi M
ClinicoEconomics and Outcomes Research 2014, 6:141-149
Published Date: 1 April 2014
Cost-effectiveness analysis of orbital atherectomy plus balloon angioplasty vs balloon angioplasty alone in subjects with calcified femoropopliteal lesions
Weinstock B, Dattilo R, Diage T
ClinicoEconomics and Outcomes Research 2014, 6:133-139
Published Date: 19 March 2014
Comparative cost effectiveness of Coflex® interlaminar stabilization versus instrumented posterolateral lumbar fusion for the treatment of lumbar spinal stenosis and spondylolisthesis
Schmier JK, Halevi M, Maislin G, Ong K
ClinicoEconomics and Outcomes Research 2014, 6:125-131
Published Date: 18 March 2014
Health economic analyses in medical nutrition: a systematic literature review
Walzer S, Droeschel D, Nuijten M, Chevrou-Séverac H
ClinicoEconomics and Outcomes Research 2014, 6:109-124
Published Date: 10 March 2014
The cost of antiretroviral treatment service for patients with HIV/AIDS in a central outpatient clinic in Vietnam
Nguyen LT, Tran BX, Tran CT, Le HT, Tran SV
ClinicoEconomics and Outcomes Research 2014, 6:101-108
Published Date: 21 February 2014
Predictors of biologic treatment of psoriasis: a non-interventional study
Puig L, Fan T, Ding Q, Smith NE
ClinicoEconomics and Outcomes Research 2014, 6:93-100
Published Date: 17 February 2014
Antibiotic expected effectiveness and cost under real life microbiology: evaluation of ertapenem and ceftriaxone in the treatment of community-acquired pneumonia for elderly patients in Spain
Grau S, Lozano V, Valladares A, Cavanillas R, Xie Y, Nocea G
ClinicoEconomics and Outcomes Research 2014, 6:83-92
Published Date: 13 February 2014
Duloxetine treatment adherence across mental health and chronic pain conditions
Able SL, Cui Z, Shen W
ClinicoEconomics and Outcomes Research 2014, 6:75-81
Published Date: 11 February 2014
Management of sacroiliac joint disruption and degenerative sacroiliitis with nonoperative care is medical resource-intensive and costly in a United States commercial payer population
Ackerman SJ, Polly Jr DW, Knight T, Holt T, Cummings J
ClinicoEconomics and Outcomes Research 2014, 6:63-74
Published Date: 11 February 2014
Cost-effectiveness of ticagrelor versus clopidogrel in patients with acute coronary syndromes in Canada
Grima DT, Brown ST, Kamboj L, Bainey KR, Goeree R, Oh P, Ramanathan K, Goodman SG
ClinicoEconomics and Outcomes Research 2014, 6:49-62
Published Date: 24 January 2014
Cost-effectiveness analysis of Mammostrat® compared with Oncotype DX® to inform the treatment of breast cancer
Mislick K, Schonfeld W, Bodnar C, Tong KB
ClinicoEconomics and Outcomes Research 2014, 6:37-47
Published Date: 16 January 2014
Out-of-pocket cost of managing sick newborns in Enugu, southeast Nigeria
Ekwochi U, Osuorah DC, Ndu IK, Ezenwosu OU, Amadi OF, Nwokoye IC, Odetunde OI
ClinicoEconomics and Outcomes Research 2014, 6:29-35
Published Date: 16 January 2014
Estimation of utility values from visual analog scale measures of health in patients undergoing cardiac surgery
Oddershede L, Andreasen JJ, Ehlers L
ClinicoEconomics and Outcomes Research 2014, 6:21-27
Published Date: 10 January 2014
Health care-resource utilization before and after natalizumab initiation in multiple sclerosis patients in the US
Bonafede MM, Johnson BH, Watson C
ClinicoEconomics and Outcomes Research 2014, 6:11-20
Published Date: 19 December 2013
Budget impact analysis of the fentanyl buccal tablet for treatment of breakthrough cancer pain
Darbà J, Kaskens L, Sánchez-de la Rosa R
ClinicoEconomics and Outcomes Research 2014, 6:1-9
Published Date: 16 December 2013
C-QUALITY: cost and quality-of-life pharmacoeconomic analysis of antidepressants used in major depressive disorder in the regional Italian settings of Veneto and Sardinia
Mencacci C, Aguglia E, Biggio G, Cappellari L, Di Sciascio G, Fagiolini A, Maina G, Tortorella A, Katz P, Ripellino C
ClinicoEconomics and Outcomes Research 2013, 5:611-621
Published Date: 3 December 2013
Health economic evidence of 5% lidocaine medicated plaster in post-herpetic neuralgia
Liedgens H, Obradovic M, Nuijten M
ClinicoEconomics and Outcomes Research 2013, 5:597-609
Published Date: 25 November 2013
Persistence with weekly and monthly bisphosphonates among postmenopausal women: analysis of a US pharmacy claims administrative database
Fan T, Zhang Q, Sen SS
ClinicoEconomics and Outcomes Research 2013, 5:589-595
Published Date: 19 November 2013
Comparison of the costs of nonoperative care to minimally invasive surgery for sacroiliac joint disruption and degenerative sacroiliitis in a United States Medicare population: potential economic implications of a new minimally-invasive technology
Ackerman SJ, Polly Jr DW, Knight T, Schneider K, Holt T, Cummings J
ClinicoEconomics and Outcomes Research 2013, 5:575-587
Published Date: 20 November 2013
Challenges in measuring and valuing productivity costs, and their relevance in mood disorders
Lensberg BR, Drummond MF, Danchenko N, Despiégel N, François C
ClinicoEconomics and Outcomes Research 2013, 5:565-573
Published Date: 18 November 2013
Cost-effectiveness of modified-release prednisone in the treatment of moderate to severe rheumatoid arthritis with morning stiffness based on directly elicited public preference values
Dunlop W, Iqbal I, Khan I, Ouwens M, Heron L
ClinicoEconomics and Outcomes Research 2013, 5:555-564
Published Date: 30 October 2013
Budget impact analysis of conversion from cyclosporine to sirolimus as immunosuppressive medication in renal transplantation therapy
Foroutan N, Rasekh HR, Salamzadeh J, Jamshidi HR, Nafar M
ClinicoEconomics and Outcomes Research 2013, 5:545-553
Published Date: 18 October 2013
A systematic review of the effectiveness of taxes on nonalcoholic beverages and high-in-fat foods as a means to prevent obesity trends
Maniadakis N, Kapaki V, Damianidi L, Kourlaba G
ClinicoEconomics and Outcomes Research 2013, 5:519-543
Published Date: 22 October 2013
Outcomes associated with conventional versus lipid-based formulations of amphotericin B in propensity-matched groups
Campbell RS, Chaudhari P, Hays HD, Taylor RJ, Nathanson BH, Bozzette SA, Horn DL
ClinicoEconomics and Outcomes Research 2013, 5:507-517
Published Date: 24 October 2013
Real-world outcomes of initiating insulin glargine-based treatment versus premixed analog insulins among US patients with type 2 diabetes failing oral antidiabetic drugs
Baser O, Tangirala K, Wei W, Xie L
ClinicoEconomics and Outcomes Research 2013, 5:497-505
Published Date: 3 October 2013
Economic evaluation of initial antiretroviral therapy for HIV-infected patients: an update of Italian guidelines
Colombo GL, Matteo SD, Antinori A, Medaglia M, Murachelli S, Rizzardini G
ClinicoEconomics and Outcomes Research 2013, 5:489-496
Published Date: 3 October 2013
Cost of noninfectious comorbidities in patients with HIV
Guaraldi G, Zona S, Menozzi M, Carli F, Bagni P, Berti A, Rossi E, Orlando G, Zoboli G, Palella F
ClinicoEconomics and Outcomes Research 2013, 5:481-488
Published Date: 23 September 2013
Using observational data to inform the design of a prospective effectiveness study for a novel insulin delivery device
Grabner M, Chen Y, Nguyen M, Abbott SD, Quimbo R
ClinicoEconomics and Outcomes Research 2013, 5:471-479
Published Date: 23 September 2013
Long-term cost-effectiveness of atypical antipsychotics in the treatment of adults with schizophrenia in the US
O'Day K, Rajagopalan K, Meyer K, Pikalov A, Loebel A
ClinicoEconomics and Outcomes Research 2013, 5:459-470
Published Date: 13 September 2013
Economic burden of inpatient and outpatient antibiotic treatment for methicillin-resistant Staphylococcus aureus complicated skin and soft-tissue infections: a comparison of linezolid, vancomycin, and daptomycin
Stephens JM, Gao X, Patel DA, Verheggen BG, Shelbaya A, Haider S
ClinicoEconomics and Outcomes Research 2013, 5:447-457
Published Date: 16 September 2013
Cost-effectiveness of the once-daily efavirenz/emtricitabine/tenofovir tablet compared with the once-daily elvitegravir/cobicistat/emtricitabine/tenofovir tablet as first-line antiretroviral therapy in HIV-infected adults in the US
Juday T, Correll T, Anene A, Broder MS, Ortendahl J, Bentley T
ClinicoEconomics and Outcomes Research 2013, 5:437-445
Published Date: 2 September 2013
Early enteral nutrition in critical illness: a full economic analysis using US costs
Doig GS, Chevrou-Séverac H, Simpson F
ClinicoEconomics and Outcomes Research 2013, 5:429-436
Published Date: 23 August 2013
Cost and clinical consequences of smoking cessation in outpatients after cardiovascular disease: a retrospective cohort study
Sicras-Mainar A, Díaz-Cerezo S, Sanz de Burgoa V, Navarro-Artieda R
ClinicoEconomics and Outcomes Research 2013, 5:419-427
Published Date: 19 August 2013
The personal, societal, and economic burden of schizophrenia in the People's Republic of China: implications for antipsychotic therapy
Montgomery W, Liu L, Stensland MD, Xue HB, Treuer T, Ascher-Svanum H
ClinicoEconomics and Outcomes Research 2013, 5:407-418
Published Date: 14 August 2013
Impact of scribes on patient interaction, productivity, and revenue in a cardiology clinic: a prospective study
Bank AJ, Obetz C, Konrardy A, Khan A, Pillai KM, McKinley BJ, Gage RM, Turnbull MA, Kenney WO
ClinicoEconomics and Outcomes Research 2013, 5:399-406
Published Date: 9 August 2013
Economic evaluation of highly purified human menopausal gonadotropin versus recombinant human follicle-stimulating hormone in fresh and frozen in vitro fertilization/intracytoplasmic sperm-injection cycles in Sweden
Wex J, Abou-Setta AM
ClinicoEconomics and Outcomes Research 2013, 5:381-397
Published Date: 9 August 2013
Early parenteral nutrition in critically ill patients with short-term relative contraindications to early enteral nutrition: a full economic analysis of a multicenter randomized controlled trial based on US costs
Doig GS, Simpson F
ClinicoEconomics and Outcomes Research 2013, 5:369-379
Published Date: 22 July 2013
Resource use and costs of exenatide bid or insulin in clinical practice: the European CHOICE study
Kiiskinen U, Matthaei S, Reaney M, Mathieu C, Östenson C-G, Krarup T, Theodorakis M, Kiljański J, Salaun-Martin C, Sapin H, Guerci B
ClinicoEconomics and Outcomes Research 2013, 5:355-367
Published Date: 11 July 2013
Retrospective claims analysis of best supportive care costs and survival in a US metastatic renal cell population
Henk HJ, Chen C, Benedict A, Sullivan J, Teitelbaum A
ClinicoEconomics and Outcomes Research 2013, 5:347-354
Published Date: 9 July 2013
Changes in quality of care and costs induced by implementation of a diabetes program in a social security entity of Argentina
González L, Elgart JF, Calvo H, Gagliardino JJ
ClinicoEconomics and Outcomes Research 2013, 5:337-345
Published Date: 4 July 2013
Cost-effectiveness of bazedoxifene versus raloxifene in the treatment of postmenopausal women in Spain
Darbà J, Pérez-Álvarez N, Kaskens L, Holgado-Pérez S, Racketa J, Rejas J
ClinicoEconomics and Outcomes Research 2013, 5:327-336
Published Date: 5 July 2013
Cost-effectiveness of zofenopril in patients with left ventricular systolic dysfunction after acute myocardial infarction: a post hoc analysis of SMILE-4
Borghi C, Ambrosioni E, Omboni S, Cicero AFG, Bacchelli S, Degli Esposti D, Novo S, Vinereanu D, Ambrosio G, Reggiardo G, Zava D
ClinicoEconomics and Outcomes Research 2013, 5:317-325
Published Date: 8 July 2013
A cost-of-illness study of spina bifida in Italy
Colombo GL, Di Matteo S, Vinci M, Gatti C, Pascali MP, De Gennaro M, Macrellino E, Mosiello G, Redaelli T, Schioppa F, Dieci C
ClinicoEconomics and Outcomes Research 2013, 5:309-316
Published Date: 2 July 2013
Cost–utility analysis for platinum-sensitive recurrent ovarian cancer therapy in South Korea: results of the polyethylene glycolated liposomal doxorubicin/carboplatin sequencing model
Lee HY, Yang BM, Hong JM, Lee TJ, Kim BG, Kim JW, Kim YT, Kim YM, Kang S
ClinicoEconomics and Outcomes Research 2013, 5:297-307
Published Date: 3 July 2013
Fluid overload is associated with increases in length of stay and hospital costs: pooled analysis of data from more than 600 US hospitals
Magee G, Zbrozek A
ClinicoEconomics and Outcomes Research 2013, 5:289-296
Published Date: 26 June 2013
The costs of traumatic brain injury: a literature review
Humphreys I, Wood RL, Phillips CJ, Macey S
ClinicoEconomics and Outcomes Research 2013, 5:281-287
Published Date: 26 June 2013
Demographics and clinical and economic characteristics of patients receiving total hip arthroplasty with and without muscle atrophy/weakness
Wu N, Chen SY, Lee YC, Zhao Y
ClinicoEconomics and Outcomes Research 2013, 5:271-280
Published Date: 25 June 2013
Leuprolide acetate 1-, 3- and 6-monthly depot formulations in androgen deprivation therapy for prostate cancer in nine European countries: evidence review and economic evaluation
Wex J, Sidhu M, Odeyemi I, Abou-Setta AM, Retsa P, Tombal B
ClinicoEconomics and Outcomes Research 2013, 5:257-269
Published Date: 24 June 2013
Estimating the long-term effects of in vitro fertilization in Greece: an analysis based on a lifetime-investment model
Fragoulakis V, Maniadakis N
ClinicoEconomics and Outcomes Research 2013, 5:247-255
Published Date: 20 June 2013
The clinical and economic burden of chronic obstructive pulmonary disease in the USA
Guarascio AJ, Ray SM, Finch CK, Self TH
ClinicoEconomics and Outcomes Research 2013, 5:235-245
Published Date: 17 June 2013
Medical technology as a key driver of rising health expenditure: disentangling the relationship
Sorenson C, Drummond M, Bhuiyan Khan B
ClinicoEconomics and Outcomes Research 2013, 5:223-234
Published Date: 30 May 2013
Antiretroviral treatment switch strategies for lowering the costs of antiretroviral therapy in subjects with suppressed HIV-1 viremia in Spain
Llibre JM, Cardona G, Santos JR, Andreu A , Estrada JO, Ara J, Bonafont X, Clotet B
ClinicoEconomics and Outcomes Research 2013, 5:215-221
Published Date: 23 May 2013
Annual cost of hospitalization, inpatient rehabilitation, and sick leave for head and neck cancers in Germany
Klussmann JP, Schädlich PK, Chen X, Rémy V
ClinicoEconomics and Outcomes Research 2013, 5:203-213
Published Date: 16 May 2013
Glycemic control and diabetes-related health care costs in type 2 diabetes; retrospective analysis based on clinical and administrative databases
Degli Esposti L, Saragoni S, Buda S, Sturani A, Degli Esposti E
ClinicoEconomics and Outcomes Research 2013, 5:193-201
Published Date: 14 May 2013
Homozygous familial hypercholesterolemia (HoFH) in Germany: an epidemiological survey
Walzer S, Travers K, Rieder S, Erazo-Fischer E, Matusiewicz D
ClinicoEconomics and Outcomes Research 2013, 5:189-192
Published Date: 3 May 2013
Clinical and economic outcomes among hospitalized patients with acute coronary syndrome: an analysis of a national representative Medicare population
Chen SY, Crivera C, Stokes M, Boulanger L, Schein J
ClinicoEconomics and Outcomes Research 2013, 5:181-188
Published Date: 1 May 2013
Health-resource use and costs associated with fibromyalgia in France, Germany, and the United States
Knight T, Schaefer C, Chandran A, Zlateva G, Winkelmann A, Perrot S
ClinicoEconomics and Outcomes Research 2013, 5:171-180
Published Date: 23 April 2013
Comparison of health care resource utilization and costs among patients with GERD on once-daily or twice-daily proton pump inhibitor therapy
Mody R, Eisenberg D, Hou L, Kamat S, Singer J, Gerson LB
ClinicoEconomics and Outcomes Research 2013, 5:161-169
Published Date: 22 April 2013
Improving the economic and humanistic outcomes for diabetic patients: making a case for employer-sponsored medication therapy management
Pinto SL, Kumar J, Partha G, Bechtol RA
ClinicoEconomics and Outcomes Research 2013, 5:153-159
Published Date: 11 April 2013
Update on the management of cirrhosis – focus on cost-effective preventative strategies
Neff GW, Kemmer N, Duncan C, Alsina A
ClinicoEconomics and Outcomes Research 2013, 5:143-152
Published Date: 12 April 2013
Update on the treatment of non-small-cell lung cancer: focus on the cost-effectiveness of new agents
Vergnenègre A, Borget I, Chouaid C
ClinicoEconomics and Outcomes Research 2013, 5:137-141
Published Date: 10 April 2013
An Italian cost-effectiveness analysis of paclitaxel albumin (nab-paclitaxel) versus conventional paclitaxel for metastatic breast cancer patients: the COSTANza study
Lazzaro C, Bordonaro R, Cognetti F, Fabi A, De Placido S, Arpino G, Marchetti P, Botticelli A, Pronzato P, Martelli E
ClinicoEconomics and Outcomes Research 2013, 5:125-135
Published Date: 11 April 2013
Follow-up analysis of federal process of care data reported from three acute care hospitals in rural Appalachia
Sills ES, Chiriac L, Vaughan D, Jones CA, Salem SA
ClinicoEconomics and Outcomes Research 2013, 5:119-124
Published Date: 27 March 2013
The role and uptake of private health insurance in different health care systems: are there lessons for developing countries?
Odeyemi IA, Nixon J
ClinicoEconomics and Outcomes Research 2013, 5:109-118
Published Date: 5 March 2013
Health care costs associated with venous thromboembolism in selected high-risk ambulatory patients with solid tumors undergoing chemotherapy in the United States
Khorana AA, Dalal MR, Lin J, Connolly GC
ClinicoEconomics and Outcomes Research 2013, 5:101-108
Published Date: 13 February 2013
Cost-effectiveness evaluation of escitalopram in major depressive disorder in Italy
Mencacci C, Di Sciascio G, Katz P, Ripellino C
ClinicoEconomics and Outcomes Research 2013, 5:87-99
Published Date: 7 February 2013
Do different clinical evidence bases lead to discordant health-technology assessment decisions? An in-depth case series across three jurisdictions
Spinner DS, Birt J, Walter JW, Bowman L, Mauskopf J, Drummond MF, Copley-Merriman C
ClinicoEconomics and Outcomes Research 2013, 5:69-85
Published Date: 30 January 2013
Antiretroviral therapy in HIV-infected patients: a proposal to assess the economic value of the single-tablet regimen
Colombo GL, Di Matteo S, Maggiolo F
ClinicoEconomics and Outcomes Research 2013, 5:59-68
Published Date: 12 February 2013
Medical costs and utilization in patients with depression treated with adjunctive atypical antipsychotic therapy
Nadkarni A, Kalsekar I, You M, Forbes R, Hebden T
ClinicoEconomics and Outcomes Research 2013, 5:49-57
Published Date: 20 January 2013
Health care costs before and after diagnosis of depression in patients with unexplained pain: a retrospective cohort study using the United Kingdom General Practice Research Database
Reed C, Hong J, Novick D, Lenox-Smith A, Happich M
ClinicoEconomics and Outcomes Research 2013, 5:37-47
Published Date: 14 January 2013
Estimating the willingness to pay for a quality-adjusted life year in Thailand: does the context of health gain matter?
Thavorncharoensap M, Teerawattananon Y, Natanant S, Kulpeng W, Yothasamut J, Werayingyong P
ClinicoEconomics and Outcomes Research 2013, 5:29-36
Published Date: 10 January 2013
Cost-effectiveness of dronedarone and standard of care compared with standard of care alone: US results of an ATHENA lifetime model
Reynolds MR, Nilsson J, Åkerborg Ö, Jhaveri M, Lindgren P
ClinicoEconomics and Outcomes Research 2013, 5:19-28
Published Date: 8 January 2013
Epidemiology of falls and osteoporotic fractures: a systematic review
Morrison A, Fan T, Sen SS, Weisenfluh L
ClinicoEconomics and Outcomes Research 2013, 5:9-18
Published Date: 28 December 2012
Analysis of disease patterns and cost of treatments for prevention of deep venous thrombosis after total knee or hip replacement: results from the Practice Analysis of THromboprophylaxis after Orthopaedic Surgery (PATHOS) study
Degli Esposti L, Didoni G, Simon T, Buda S, Sangiorgi D, Degli Esposti E
ClinicoEconomics and Outcomes Research 2013, 5:1-7
Published Date: 28 December 2012
Increase in direct diabetes-related costs and resource use in the 6 months following initiation of insulin in patients with type 2 diabetes in five European countries: data from the INSTIGATE study
Jones S, Castell C, Goday A, Smith HT, Nicolay C, Simpson A, Salaun-Martin C
ClinicoEconomics and Outcomes Research 2012, 4:383-393
Published Date: 20 December 2012
Cost and appropriateness of treating asthma with fixed-combination drugs in local health care units in Italy
Ruggeri I, Bragato D, Colombo GL, Valla E, Di Matteo S
ClinicoEconomics and Outcomes Research 2012, 4:375-382
Published Date: 5 December 2012
The use of comparative effectiveness research to inform policy decisions on the inclusion of bevacizumab for the treatment of macular diseases in Thailand's pharmaceutical benefit package
Anothaisintawee T, Leelahavarong P, Ratanapakorn T, Teerawattananon Y
ClinicoEconomics and Outcomes Research 2012, 4:361-374
Published Date: 6 December 2012
Budget impact analysis of boceprevir and telaprevir for the treatment of hepatitis C genotype 1 infection
Thorlund K, Druyts E, El Khoury AC, Mills EJ
ClinicoEconomics and Outcomes Research 2012, 4:349-359
Published Date: 16 November 2012
The impact of initial statin treatment decisions on cardiovascular outcomes in clinical care settings: estimates using the Archimedes Model
van Herick A, Schuetz CA, Alperin P, Bullano MF, Balu S, Gandhi S
ClinicoEconomics and Outcomes Research 2012, 4:337-347
Published Date: 9 November 2012
Economic analysis of Heart and Stroke Foundation of Ontario's Hypertension Management Initiative
de Oliveira C, Wijeysundera HC, Tobe SW, Moy Lum-Kwong M, Von Sychowski S, Wang X, Tu JV, Krahn MD
ClinicoEconomics and Outcomes Research 2012, 4:323-336
Published Date: 13 November 2012
Cost-effectiveness of candesartan versus losartan in the primary preventive treatment of hypertension
Granström O, Levin LA, Henriksson M
ClinicoEconomics and Outcomes Research 2012, 4:313-322
Published Date: 1 November 2012
Impact of dry eye on work productivity
Yamada M, Mizuno Y, Shigeyasu C
ClinicoEconomics and Outcomes Research 2012, 4:307-312
Published Date: 10 October 2012
Societal savings in patients with advanced non-squamous non-small-cell lung cancer receiving bevacizumab-based versus non-bevacizumab-based treatments in France, Germany, Italy, and Spain
Lister J, Stanisic S, Kaier K, Hagist C, Gultyaev D, Walzer S
ClinicoEconomics and Outcomes Research 2012, 4:299-305
Published Date: 4 October 2012
Cost-effectiveness analysis of intranasal live attenuated vaccine (LAIV) versus injectable inactivated influenza vaccine (TIV) for Canadian children and adolescents
Tarride JE, Burke N, Von Keyserlingk C, O'Reilly D, Xie F, Goeree R
ClinicoEconomics and Outcomes Research 2012, 4:287-298
Published Date: 4 October 2012
Two-factor theory – at the intersection of health care management and patient satisfaction
Bohm J
ClinicoEconomics and Outcomes Research 2012, 4:277-285
Published Date: 4 October 2012
Maintenance erlotinib in advanced nonsmall cell lung cancer: cost-effectiveness in EGFR wild-type across Europe
Walleser S, Ray J, Bischoff H, Vergnenègre A, Rosery H, Chouaid C, Heigener D, de Castro Carpeño J, Tiseo M, Walzer S
ClinicoEconomics and Outcomes Research 2012, 4:269-275
Published Date: 14 September 2012
Calcipotriol and betamethasone dipropionate in the treatment of mild-to-moderate psoriasis: a cost-effectiveness analysis of the ointment versus gel formulation
Colombo GL, Di Matteo S, Bruno G, Girolomoni G, Vena GA
ClinicoEconomics and Outcomes Research 2012, 4:261-268
Published Date: 13 September 2012
Budget impact analysis of two immunotherapy products for treatment of grass pollen-induced allergic rhinoconjunctivitis
Rønborg SM, Svendsen UG, Micheelsen JS, Ytte L, Andreasen JN, Ehlers L
ClinicoEconomics and Outcomes Research 2012, 4:253-260
Published Date: 11 September 2012
Cost of human immunodeficiency virus infection in Italy, 2007–2009: effective and expensive, are the new drugs worthwhile?
Rizzardini G, Restelli U, Bonfanti P, Porazzi E, Ricci E, Foglia E, Carenzi L, Croce D
ClinicoEconomics and Outcomes Research 2012, 4:245-252
Published Date: 5 September 2012
Cost comparison of second-line treatment options for late stage non-small-cell lung cancer: cost analysis for Italy
Schwander B, Ravera S, Giuliani G, Nuijten M, Walzer S
ClinicoEconomics and Outcomes Research 2012, 4:237-243
Published Date: 3 September 2012
Cost-effectiveness of entecavir versus adefovir for the treatment of chronic hepatitis B in patients with decompensated cirrhosis from a third-party US payer perspective
Tsai N, Jeffers L, Cragin L, Sorensen S, Su W, Rosenblatt L, Tang H, Hebden T, Juday T
ClinicoEconomics and Outcomes Research 2012, 4:227-235
Published Date: 23 August 2012
Cost of rheumatoid arthritis in a selected population from Argentina in the prebiologic therapy era
Catay E, Castel del Cid C, Narváez L, Velozo EJ, Rosa JE, Catoggio LJ, Soriano ER
ClinicoEconomics and Outcomes Research 2012, 4:219-225
Published Date: 23 August 2012
Burden of Crohn’s disease: economics and quality of life aspects in Italy
Benedini V, Caporaso N, Corazza GR, Rossi Z, Fornaciari G, Cottone M, Frosini G, Caruggi M, Ottolini C, Colombo GL
ClinicoEconomics and Outcomes Research 2012, 4:209-218
Published Date: 24 July 2012
Economic evaluation of bevacizumab in the treatment of non-small cell lung cancer (NSCLC)
Chien C-R, Shih Y-C,
ClinicoEconomics and Outcomes Research 2012, 4:201-208
Published Date: 25 July 2012
New strategies for lowering the costs of antiretroviral treatment and care for people with HIV/AIDS in the United Kingdom
Gazzard B, Moecklinghoff C, Hill A
ClinicoEconomics and Outcomes Research 2012, 4:193-200
Published Date: 12 July 2012
Economic evaluation of alternative assisted reproduction techniques in management of infertility in Greece
Fragoulakis V, Kourlaba G, Tarlatzis B, Mastrominas M, Maniadakis N
ClinicoEconomics and Outcomes Research 2012, 4:185-192
Published Date: 12 July 2012
State of health economic evaluation research in Saudi Arabia: a review
Al-Aqeel SA
ClinicoEconomics and Outcomes Research 2012, 4:177-184
Published Date: 5 July 2012
Retrospective US database analysis of drug utilization patterns, health care resource use, and costs associated with adjuvant interferon alfa-2b therapy for treatment of malignant melanoma following surgery
Hackshaw MD, Krishna A, Mauro DJ
ClinicoEconomics and Outcomes Research 2012, 4:169-176
Published Date: 18 June 2012
Pregabalin versus SSRIs and SNRIs in benzodiazepine-refractory outpatients with generalized anxiety disorder: a post hoc cost-effectiveness analysis in usual medical practice in Spain
De Salas-Cansado M, Olivares JM, Álvarez E, Carrasco JL, Barrueta A, Rejas J
ClinicoEconomics and Outcomes Research 2012, 4:157-168
Published Date: 13 June 2012
Techniques for estimating health care costs with censored data: an overview for the health services researcher
Wijeysundera HC, Wang X, Tomlinson G, Ko DT, Krahn MD
ClinicoEconomics and Outcomes Research 2012, 4:145-155
Published Date: 1 June 2012
Economic evaluation of statins in high-risk patients treated for primary and secondary prevention of cardiovascular disease in Greece
Fragoulakis V, Kourlaba G, Maniadakis N
ClinicoEconomics and Outcomes Research 2012, 4:135-143
Published Date: 29 May 2012
Economic evaluation of intravenous iron treatments in the management of anemia patients in Greece
Fragoulakis V, Kourlaba G, Goumenos D, Konstantoulakis M, Maniadakis N
ClinicoEconomics and Outcomes Research 2012, 4:127-134
Published Date: 4 May 2012
Forecast model for the evaluation of economic resources employed in the health care of patients with HIV infection
Sacchi P, Patruno SFA, Bruno R, Cima SMB, Previtali P, Franchini A, Nicolini L, Rognoni C, Sacchi L, Bellazzi R, Filice G
ClinicoEconomics and Outcomes Research 2012, 4:117-126
Published Date: 11 May 2012
Evaluating the cost utility of racecadotril for the treatment of acute watery diarrhea in children: the RAWD model
Rautenberg TA, Zerwes U, Foerster D, Aultman R
ClinicoEconomics and Outcomes Research 2012, 4:109-116
Published Date: 20 April 2012
The economic impact of enoxaparin versus unfractionated heparin for prevention of venous thromboembolism in acute ischemic stroke patients
Pineo GF, Lin J, Annemans L
ClinicoEconomics and Outcomes Research 2012, 4:99-107
Published Date: 23 April 2012
Impact of screening and early detection of impaired fasting glucose tolerance and type 2 diabetes in Canada: a Markov model simulation
Mortaz S, Wessman C, Duncan R, Gray R, Badawi A
ClinicoEconomics and Outcomes Research 2012, 4:91-97
Published Date: 10 April 2012
Costs and clinical consequences of suboptimal atrial fibrillation management
Singh SN
ClinicoEconomics and Outcomes Research 2012, 4:79-90
Published Date: 26 March 2012
Cost considerations in the management of atrial fibrillation – impact of dronedarone
Khaykin Y, Shamiss Y
ClinicoEconomics and Outcomes Research 2012, 4:67-78
Published Date: 6 March 2012
Cost-effectiveness study of oral hypoglycemic agents in the treatment of outpatients with type 2 diabetes attending a public primary care clinic in Mexico City
Díaz de León-Castañeda C, Altagracia-Martínez M, Kravzov-Jinich J, Cárdenas-Elizalde MR, Moreno-Bonett C, Martínez-Núñez JM
ClinicoEconomics and Outcomes Research 2012, 4:57-65
Published Date: 7 March 2012
Health expenditure comparison of extended-release metoprolol succinate and immediate-release metoprolol tartarate
Vaidya V, Patel P
ClinicoEconomics and Outcomes Research 2012, 4:49-56
Published Date: 7 February 2012
Treatment profiles and costs of patients with chronic pain in the population setting
Sicras Mainar A, Navarro Artieda R, Villoria Morillo J, Esquivias Escobar A
ClinicoEconomics and Outcomes Research 2012, 4:39-47
Published Date: 26 January 2012
Cross-market cost-effectiveness analysis of erlotinib as first-line maintenance treatment for patients with stable non-small cell lung cancer
Vergnenègre A, Ray JA, Chouaid C, Grossi F, Bischoff HG, Heigener DF, Walzer S
ClinicoEconomics and Outcomes Research 2012, 4:31-37
Published Date: 26 January 2012
Health status, hospitalizations, day procedures, and physician costs associated with body mass index (BMI) levels in Ontario, Canada
Tarride JE, Haq M, Taylor VH, Sharma AM, Nakhai-Pour HR, O'Reilly D, Xie F, Dolovich L, Goeree R
ClinicoEconomics and Outcomes Research 2012, 4:21-30
Published Date: 24 January 2012
Predictors of antipsychotic monotherapy with olanzapine during a 1-year naturalistic study of schizophrenia patients in Japan
Ye W, Ascher-Svanum H, Flynn JA, Tanji Y, Takahashi M
ClinicoEconomics and Outcomes Research 2012, 4:13-19
Published Date: 13 January 2012
Cost-effectiveness of rosuvastatin in comparison with generic atorvastatin and simvastatin in a Swedish population at high risk of cardiovascular events
Gandhi SK, Jensen MM, Fox KM, Smolen L, Olsson AG, Paulsson T
ClinicoEconomics and Outcomes Research 2012, 4:1-11
Published Date: 10 January 2012
Cost-utility analysis of immune tolerance induction therapy versus on-demand treatment with recombinant factor VII for hemophilia A with high titer inhibitors in Iran
Rasekh HR, Imani A, Karimi M, Golestani M
ClinicoEconomics and Outcomes Research 2011, 3:207-212
Published Date: 23 November 2011
Cost-effectiveness analysis of initial HIV treatment under Italian guidelines
Colombo GL, Colangeli V, Di Biagio A, Di Matteo S, Viscoli C, Viale P
ClinicoEconomics and Outcomes Research 2011, 3:197-205
Published Date: 31 October 2011
Impact of early intervention and disease modification in patients with predementia Alzheimer’s disease: a Markov model simulation
Budd D, Burns LC, Guo Z, L’Italien G, Lapuerta P
ClinicoEconomics and Outcomes Research 2011, 3:189-195
Published Date: 7 October 2011
Corrigendum
Zoellner Y, Balp MM, Gili Marco A
ClinicoEconomics and Outcomes Research 2011, 3:187-188
Published Date: 6 September 2011
Role of centralized review processes for making reimbursement decisions on new health technologies in Europe
Stafinski T, Menon D, Davis C, McCabe C
ClinicoEconomics and Outcomes Research 2011, 3:117-186
Published Date: 30 August 2011
The role of galenic innovation in improving treatment compliance and persistence: three case studies
Zoellner Y, Balp MM, Gili Marco A
ClinicoEconomics and Outcomes Research 2011, 3:109-116
Published Date: 4 August 2011
Retrospective drug utilization review: impact of pharmacist interventions on physician prescribing
Angalakuditi M, Gomes J
ClinicoEconomics and Outcomes Research 2011, 3:105-108
Published Date: 27 June 2011
Transferability of health technology assessments and economic evaluations: a systematic review of approaches for assessment and application
Goeree R, He J, O'Reilly D, Tarride J-E, Xie F, Lim M, Burke N
ClinicoEconomics and Outcomes Research 2011, 3:89-104
Published Date: 2 June 2011
Cost-effectiveness of early responders versus early nonresponders to atypical antipsychotic therapy
Peng X, Ascher-Svanum H, Faries DE, Stauffer VL, Kollack-Walker S, Kinon BJ, Kane JM
ClinicoEconomics and Outcomes Research 2011, 3:79-87
Published Date: 20 April 2011
The economic burden of TNFα inhibitors and other biologic treatments in Norway
Jan Norum, Wenche Koldingsnes, Torfinn Aanes, et al
ClinicoEconomics and Outcomes Research 2011, 3:73-78
Published Date: 21 March 2011
Adherence and persistence with branded antidepressants and generic SSRIs among managed care patients with major depressive disorder
Xianchen Liu, Yi Chen, Douglas E Faries, et al
ClinicoEconomics and Outcomes Research 2011, 3:63-72
Published Date: 15 March 2011
Cost–utility analysis of prophylaxis versus treatment on demand in severe hemophilia A
Giorgio L Colombo, Sergio Di Matteo, Maria Elisa Mancuso, et al
ClinicoEconomics and Outcomes Research 2011, 3:55-61
Published Date: 14 March 2011
Adherence to antihypertensive medications and health outcomes among newly treated hypertensive patients
Luca Degli Esposti, Stefania Saragoni, Silvia Benemei, et al
ClinicoEconomics and Outcomes Research 2011, 3:47-54
Published Date: 7 March 2011
A cost-effectiveness analysis of different therapies in patients with chronic hepatitis B in Italy
Giorgio L Colombo, Giovanni B Gaeta, Mauro Viganò, et al
ClinicoEconomics and Outcomes Research 2011, 3:37-46
Published Date: 15 February 2011
Biosimilar medicines and cost-effectiveness
Steven Simoens
ClinicoEconomics and Outcomes Research 2011, 3:29-36
Published Date: 10 February 2011
Indirect treatment comparison of bevacizumab + interferon-α-2a vs tyrosine kinase inhibitors in first-line metastatic renal cell carcinoma therapy
Gerald HJ Mickisch, Björn Schwander, Bernard Escudier, et al
ClinicoEconomics and Outcomes Research 2011, 3:19-27
Published Date: 25 January 2011
The costs of hospitalization in patients with acute exacerbation of chronic obstructive pulmonary disease
Sevket Ozkaya, Serhat Findik, Atilla Guven Atici
ClinicoEconomics and Outcomes Research 2011, 3:15-18
Published Date: 17 January 2011
Decline in hospitalization risk and health care cost after initiation of depot antipsychotics in the treatment of schizophrenia
Xiaomei Peng, Haya Ascher-Svanum, Douglas Faries et al
ClinicoEconomics and Outcomes Research 2011, 3:9-14
Published Date: 11 January 2011
The cost-effectiveness of venous-converted acid-base and blood gas status in pulmonary medical departments
Lars Oddershede, Sabrina Storgaard Petersen, Asgerd Krogh Kristensen, et al
ClinicoEconomics and Outcomes Research 2011, 3:1-7
Published Date: 16 December 2010
Inpatient charges and mental illness: Findings from the Nationwide Inpatient Sample 1999–2007
Jim E Banta, Ivorie Belk, Kedon Newton, et al
ClinicoEconomics and Outcomes Research 2010, 2:149-158
Published Date: 11 October 2010
Cost effectiveness of cord blood versus bone marrow and peripheral blood stem cells
Thomas Bart
ClinicoEconomics and Outcomes Research 2010, 2:141-147
Published Date: 5 October 2010
Testing the generalizability of national reimbursement rates with respect to local setting: the costs of abdominal aortic aneurysm surgery in Denmark
Søren Løvstad Christensen, Mette Kjoelby, Lars Ehlers
ClinicoEconomics and Outcomes Research 2010, 2:135-139
Published Date: 14 September 2010
Pharmacotherapy in the management of early Parkinson’s disease: cost-effectiveness and patient acceptability
Esther Cubo
ClinicoEconomics and Outcomes Research 2010, 2:127-134
Published Date: 6 September 2010
On the decision rules of cost-effective treatment for patients with diabetic foot syndrome
John E Goulionis, Athanassios Vozikis, VK Benos, et al
ClinicoEconomics and Outcomes Research 2010, 2:121-126
Published Date: 17 August 2010
Antihypertensive therapy among newly treated patients: An analysis of adherence and cost of treatment over years
Luca Degli Esposti, Stefania Saragoni, Paolo Batacchi, et al
ClinicoEconomics and Outcomes Research 2010, 2:113-120
Published Date: 28 July 2010
The significance of presenteeism for the value of lost production: the case of rheumatoid arthritis
Rikke Søgaard, Jan Sørensen, Louise Linde, et al
ClinicoEconomics and Outcomes Research 2010, 2:105-112
Published Date: 16 July 2010
Impact of disability on different domains of health-related quality of life in the noninstitutionalized general population
Javier Mar, Isabel Larrañaga, Arantzazu Arrospide, et al
ClinicoEconomics and Outcomes Research 2010, 2:97-103
Published Date: 14 July 2010
Cost effectiveness and quality of life considerations in the treatment of hepatitis C infection
H Jafferbhoy, W Gashau, JF Dillon
ClinicoEconomics and Outcomes Research 2010, 2:87-96
Published Date: 14 July 2010
Cost-effectiveness analysis of corticosteroid inhaler devices in primary care asthma management: A real world observational study
Linda Kemp, John Haughney, Neil Barnes, et al
ClinicoEconomics and Outcomes Research 2010, 2:75-85
Published Date: 1 July 2010
Clinical and economic considerations of antiobesity treatment: a review of orlistat
Armineh Zohrabian
ClinicoEconomics and Outcomes Research 2010, 2:63-74
Published Date: 5 July 2010
Pharmacoeconomic considerations in the treatment of breast cancer
Athanasios Pallis, Vasiliki Tsiantou, Efi Simou, et al
ClinicoEconomics and Outcomes Research 2010, 2:47-61
Published Date: 15 June 2010
Rituximab in the treatment of B-cell non-Hodgkin lymphoma, focus on outcomes and comparative effectiveness
Firas Badin, John Hayslip
ClinicoEconomics and Outcomes Research 2010, 2:37-45
Published Date: 7 April 2010
Evaluating the cost-effectiveness of tiotropium versus salmeterol in the treatment of chronic obstructive pulmonary disease
Shalini Naik, Khalid M Kamal, Patricia A Keys, et al
ClinicoEconomics and Outcomes Research 2010, 2:25-36
Published Date: 9 March 2010
Cost-effectiveness analysis of intravenous levetiracetam versus intravenous phenytoin for early onset seizure prophylaxis after neurosurgery and traumatic brain injury
Rashid Kazerooni, Mark Bounthavong
ClinicoEconomics and Outcomes Research 2010, 2:15-23
Published Date: 5 March 2010
Use of electronic medical records in oncology outcomes research
Gena Kanas, Libby Morimoto, Fionna Mowat, et al
ClinicoEconomics and Outcomes Research 2010, 2:1-14
Published Date: 24 February 2010
Economic considerations for bariatric surgery and morbid obesity
Eldo E Frezza, Mitchell Wacthell, Bradley Ewing
ClinicoEconomics and Outcomes Research 2009, 1:79-83
Published Date: 10 December 2009
Assessing cost-effectiveness in the management of multiple sclerosis
Ceri J Phillips, Ioan Humphreys
ClinicoEconomics and Outcomes Research 2009, 1:61-78
Published Date: 18 November 2009
A cost–utility analysis of etanercept for the treatment of moderate-to-severe psoriasis in Italy
Giorgio L Colombo, Sergio Di Matteo, Ketty Peris, Maria Concetta Fargnoli, et al.
ClinicoEconomics and Outcomes Research 2009, 1:53-59
Published Date: 15 October 2009
Clinical efficacy issues in the treatment of multiple sclerosis: update of natalizumab
Francesco Patti, Angelo Pappalardo
ClinicoEconomics and Outcomes Research 2009, 1:45-51
Published Date: 21 August 2009
Economic considerations in the treatment of invasive aspergillosis: a review of voriconazole pharmacoeconomic studies
Kem P Krueger, A Christie Nelson
ClinicoEconomics and Outcomes Research 2009, 1:35-43
Published Date: 10 August 2009
Smoking cessation: an economic analysis and review of varenicline
Michele A Faulkner
ClinicoEconomics and Outcomes Research 2009, 1:25-34
Published Date: 24 June 2009
Management strategies and cost effectiveness in the prevention of cervical cancer
Smita R Prasad
ClinicoEconomics and Outcomes Research 2009, 1:17-23
Published Date: 5 June 2009
Body mass characteristics of hip osteoarthritis patients experiencing aseptic loosening, periprosthetic fractures, dislocation, and infections after total hip replacement
Ray Marks
ClinicoEconomics and Outcomes Research 2009, 1:7-16
Published Date: 15 May 2009
Breast cancer quality of life evaluation in Mexican Women at La Raza Hospital, Mexico City: A preliminary approach
Jacobo Alejandro Gómez-Rico, Marina Altagracia-Martínez, Jaime Kravzov-Jinich, Rosario Cárdenas-Elizalde, Juan Carlos Hinojosa-Cruz, Consuelo Rubio-Poo
ClinicoEconomics and Outcomes Research 2009, 1:1-6
Published Date: 30 November 2008